<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Diseases of the Esophagus via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Diseases of the Esophagus' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Diseases+of+the+Esophagus&t=Diseases+of+the+Esophagus&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 21 Mar 2010 15:07:53 +0100</lastBuildDate>
        <item>
            <title>The effect of argon plasma coagulation ablation on esophageal motility and chemoreceptor sensitivity in Barrett's esophagus patients</title>
            <link>http://www.medworm.com/index.php?rid=3344254&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2010.01047.x</link>
            <description>In conclusion, we have shown no substantive changes in esophageal motility after ablation of Barrett's esophagus cells, but have demonstrated reduced sensitivity to reflux type solutions. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3344254</comments>
            <pubDate>Tue, 09 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3344254</guid>        </item>
        <item>
            <title>Self-expandable esophageal stents placement for the palliation of dysphagia as a result of lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=3344255&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2010.01046.x</link>
            <description>We report our experience with self-expandable metallic stents for the palliation of malignant dysphagia and tracheoesophageal fistulae caused by lung cancer. Esophageal self-expandable metallic stents were deployed in 28 patients with malignant dysphagia as a result of lung cancer between August 2002 and January 2009. Mean age was 62.1 (42[ndash]77) with 26 male patients. Twenty-three patients received previous chemo-radiotheraphy and two had pneumonectomy. Tracheoesophageal fistulae were coexisting in eight patients. Stents were inserted under fluoroscopic control over guide-wire with the patient under conscious sedation. One stent was used in all patients except one fistula patient with two stents. Immediate improvement after stent insertion was seen in all patients. Fistulae were sealed...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3344255</comments>
            <pubDate>Mon, 08 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3344255</guid>        </item>
        <item>
            <title>Surgical management for small cell carcinoma of the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=3199218&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01045.x</link>
            <description>Esophageal small cell carcinoma (SmCC) has been regarded as a rare and aggressive tumor with early metastasis. The optimal treatment has not yet been established, and the role of surgery has remained controversial. In this retrospective study, we report seven cases studies of SmCC of the esophagus and analyze the clinical outcomes after surgery. Between 1986 and 2007, there were seven patients with esophageal SmCC treated surgically in our institution. All the patients with clinically limited disease underwent transthoracic esophagectomy with lymphadenectomy. Lymph node involvement was found in all cases irrespective of the depth of tumor invasion. Three of the seven patients were diagnosed as having an extensive disease on pathological examination after esophagectomy. Five patients receiv...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199218</comments>
            <pubDate>Sat, 23 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199218</guid>        </item>
        <item>
            <title>Expression of p53 as predictor for the development of esophageal cancer in achalasia patients</title>
            <link>http://www.medworm.com/index.php?rid=3199223&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01040.x</link>
            <description>Patients with longstanding achalasia have an increased risk of developing esophageal cancer. Surveillance is hampered by chronic stasis. We investigated whether aberrant expressions of tumor suppressor gene p53 and proliferation marker ki67 are early predictors for progression to malignancy. In 399 achalasia patients, 4% died of esophageal cancer despite surveillance. We performed a cohort study, using surveillance biopsies from 18 patients (11 carcinoma, one high-grade dysplasia [HGD], and six low-grade dysplasia [LGD]) and 10 controls (achalasia patients without cancer or dysplasia development). One hundred sixty-four biopsies were re-evaluated and studied for p53 and ki67 expression using immunohistochemistry. Eighty-two percent of patients with cancer/HGD showed p53 overexpression in s...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199223</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199223</guid>        </item>
        <item>
            <title>Pharyngolaryngeal reflux in patients who underwent cervical esophago-gastrostomy following esophagectomy</title>
            <link>http://www.medworm.com/index.php?rid=3199222&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01041.x</link>
            <description>Pharyngolaryngeal reflux has been generally accepted as a cause for pharyngolaryngitis, hoarseness, aspiration pneumonia, chronic cough, and nocturnal asthma. Although patients who have undergone gastric conduit reconstruction after esophagectomy are at a high risk to pharyngolaryngeal reflux disease (PLRD), PLRD after esophagectomy is still unknown. The aim of this study is to investigate the correlation between reflux pharyngolaryngitis and acid reflux into the hypopharynx and into the cervical esophagus in patients who have undergone cervical esophagogastrostomy. We enrolled 62 patients who received follow-up endoscopy and 24-h pH monitoring after cervical esophagogastrostomy. These included 26 at 1 month after surgery and 36 at 1 year or more after surgery. We investigated: (i) the cor...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199222</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199222</guid>        </item>
        <item>
            <title>Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia</title>
            <link>http://www.medworm.com/index.php?rid=3199221&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01042.x</link>
            <description>Esophagectomy (EG) and endoscopic therapy (ET) can eradicate Barrett's esophagus with early neoplasia. Their relative effect on quality of life is unknown. The 36-item Short Form Health Survey (SF-36) and Gastrointestinal Quality of Life Index (GIQLI) questionnaires were sent to all patients who underwent either EG or ET at our institution over the last 9 years. Groups were stratified by age and American Society of Anesthesia (ASA) class. Surveys were sent to 77 patients and completed by 14 EG (50%) and by 28 ET patients (57%). The average time between treatment and survey was 4 years in the ET group and 5 years in the EG group. There were no significant differences in SF-36 scores between EG and ET patients except for superior physical functioning among EG patients 65 and older QOL scores...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199221</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199221</guid>        </item>
        <item>
            <title>Upregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern China</title>
            <link>http://www.medworm.com/index.php?rid=3199220&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01043.x</link>
            <description>Caspase-3 plays an important role as the key effector during apoptosis, but there are very few studies of caspase-3 in esophageal squamous cell carcinoma (ESCC). The purpose of this study was to investigate the expression and prognostic significance of caspase-3 in ESCC from Linzhou City, a high incidence area in northern China. All 64 patients underwent esophagectomy for ESCC between January 2002 and December were enrolled in this study. Caspase-3 expression was assessed by immunohistochemistry (IHC) in primary ESCC and paired normal esophageal epithelium. The positive rate of caspase-3 expression was higher in ESCC than in normal esophageal epithelium (79.7% vs. 50.0%, Chi-square = 12.372, P= 0.001). Caspase-3 expression was correlated with tumor cell differentiation (Phi = 0.717, P &lt; 0....</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199220</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199220</guid>        </item>
        <item>
            <title>Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability*</title>
            <link>http://www.medworm.com/index.php?rid=3199219&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01044.x</link>
            <description>This study evaluates fusion of FDG-PET and CT in patients with esophageal cancer in terms of geographic misses and inter-observer variability in volume definition. In 28 esophageal cancer patients, gross, clinical and planning tumor volumes (GTV; CTV; PTV) were defined on planning CT by three radiation oncologists. After software-based emission tomography and computed tomography (PET/CT) fusion, tumor delineations were redefined by the same radiation-oncologists. Concordance indexes (CCI's) for CT and PET/CT based GTV, CTV and PTV were calculated for each pair of observers. Incorporation of PET/CT modified tumor delineation in 17/28 subjects (61%) in cranial and/or caudal direction. Mean concordance indexes for CT-based CTV and PTV were 72 (55[ndash]86)% and 77 (61[ndash]88)%, respectively...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3199219</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3199219</guid>        </item>
        <item>
            <title>Prospective evaluation of narrow-band imaging endoscopy for screening of esophageal squamous mucosal high-grade neoplasia in experienced and less experienced endoscopists</title>
            <link>http://www.medworm.com/index.php?rid=3190927&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01039.x</link>
            <description>In conclusion, compared with the gold standard of chromoendoscopy with iodine staining, the sensitivity of NBI for screening of mucosal high-grade neoplasia was 100% with the experienced endoscopists but was low with the less experienced endoscopists. Electronic chromoendoscopy with NBI is a promising screening tool in these high-risk patients with esophageal mucosal high-grade neoplasia, particularly when performed by endoscopists with experience of using NBI. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190927</comments>
            <pubDate>Thu, 21 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190927</guid>        </item>
        <item>
            <title>CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance</title>
            <link>http://www.medworm.com/index.php?rid=3190933&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01033.x</link>
            <description>This study was designed to investigate the clinical significance of bone marrow micrometastases detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in patients with esophageal cancer. Expression of CK19 mRNA in the bone marrow of 61 patients with esophageal squamous cell carcinoma (ESCC) and 15 benign pulmonary and esophageal disease patients was assessed via RT-PCR. Correlation of CK19 mRNA expression to the clinicopathologic features and prognosis of the 61 patients was analyzed: 21.3% (13/61) were positive for expression of CK19 mRNA in patients with ESCC. No CK19 mRNA was detected of the 15 benign pulmonary and esophageal disease patients. CK19 mRNA expression did not correlate with the clinicopathologic features of the patients with ESCC, but patients with CK19 mRNA-p...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190933</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190933</guid>        </item>
        <item>
            <title>Gastroduodenal reflux induces group IIa secretory phospholipase A2 expression and activity in murine esophagus</title>
            <link>http://www.medworm.com/index.php?rid=3190932&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01034.x</link>
            <description>Exposure of esophageal epithelium to gastric and duodenal contents results in the histologic changes of hyperproliferation and mucosal thickening. We have previously shown that presence of secretory phospholipase A2 (sPLA2) is necessary to produce these histologic changes in a murine model of gastroduodenal reflux. We sought to determine the influence of gastroduodenal reflux (GDR) on sPLA2 protein and mRNA levels as well as enzyme activity in esophageal tissue. BALB/c (sPLA2+/+) mice (n= 28) underwent side-to-side surgical anastomosis of the first portion of the duodenum and GE junction (DGEA) resulting in continuous exposure of esophageal mucosa to mixed gastric and duodenal contents. Sham control mice (n= 14) underwent laparotomy, esophagotomy and closure. Real-time RT PCR was used to q...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190932</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190932</guid>        </item>
        <item>
            <title>The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features</title>
            <link>http://www.medworm.com/index.php?rid=3190931&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01035.x</link>
            <description>In this study, the expression patterns of CFL1 and N-WASP in normal esophageal mucosa and esophageal squamous cell carcinoma (ESCC) and their correlation with clinical characteristics were investigated. Immunohistochemical staining showed that CFL1 was expressed in nuclear and cytoplasm of cancer cells. However, N-WASP was mainly found in the cytoplasm of the cancer cells. There were significant evidences that proved that CFL1 is correlated with clinicopathological factors in ESCC, such as infiltration depth, lymph node metastasis and pathological staging (P &lt; 0.05). It is also proved that N-WASP is related to lymph node metastasis and pathological staging in ESCC (P &lt; 0.05). Kaplan[ndash]Meier analysis showed that there was no correlation between CFL1 and N-WASP protein expression and sur...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190931</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190931</guid>        </item>
        <item>
            <title>Endostitch-assisted endoscopic Zenker's diverticulostomy: a tried approach for difficult cases</title>
            <link>http://www.medworm.com/index.php?rid=3190930&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01036.x</link>
            <description>We report on our experience using a previously described technique specifically for difficult, unfavorable, or contraindicated cases and suggest the employment of this technique as an alternative method to facilitate endoscopic repair and possibly limit the need for an open approach. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190930</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190930</guid>        </item>
        <item>
            <title>Esophageal motion during radiotherapy: quantification and margin implications</title>
            <link>http://www.medworm.com/index.php?rid=3190929&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01037.x</link>
            <description>The purpose was to evaluate interfraction and intrafraction esophageal motion in the right[ndash]left (RL) and anterior[ndash]posterior (AP) directions using computed tomography (CT) in esophageal cancer patients. Eight patients underwent CT simulation and CT-on-rails imaging before and after radiotherapy. Interfraction displacement was defined as differences between pretreatment and simulation images. Intrafraction displacement was defined as differences between pretreatment and posttreatment images. Images were fused using bone registries, adjusted to the carina. The mean, average of the absolute, and range of esophageal motion were calculated in the RL and AP directions, above and below the carina. Thirty-one CT image sets were obtained. The incidence of esophageal interfraction motion ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190929</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190929</guid>        </item>
        <item>
            <title>Excessive belching and aerophagia: two different disorders</title>
            <link>http://www.medworm.com/index.php?rid=3190928&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01038.x</link>
            <description>Belching is physiological venting of excessive gastric air. Excessive and bothersome belching is a common symptom, which is often seen in patients with functional dyspepsia and gastroesophageal reflux disease. Other symptoms are usually predominant. However, a small group of patients complain of isolated excessive belching, with a frequency of several belches per minute. In these patients, the eructated air does not originate from the stomach but is sucked or injected in the esophagus from the pharynx and expelled immediately afterward in oral direction. This behavior is called supragastric belching because the air does not originate from the stomach and does not reach the stomach either. Excessive belching can be treated by speech therapy or behavior therapy. The term aerophagia should be...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190928</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190928</guid>        </item>
        <item>
            <title>Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results</title>
            <link>http://www.medworm.com/index.php?rid=3083589&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01028.x</link>
            <description>Few studies had evaluated the results of proton pump inhibitors on distal and proximal pH recording using a dual-channel probe. The aim of this study was to determine the clinical and pH-metric effect of treatment with pantoprazole 80 mg for 8 weeks in patients with ear, nose, and throat (ENT) manifestations of gastroesophageal reflux disease associated with pathological proximal acid exposure. We conducted a prospective open study. Patients included had to have chronic pharyngitis or laryngitis, and a pathological gastroesophagopharyngeal reflux. All patients received treatment with pantoprazole 80 mg daily for 8 weeks. One week after the end treatment, patients had a second ENT examination and a 24-hour pH monitoring using dual-channel probe. We included 33 patients (11 men, 22 women). A...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3083589</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3083589</guid>        </item>
        <item>
            <title>CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3083588&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01029.x</link>
            <description>In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3+ T-regs in ESCC. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3083588</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3083588</guid>        </item>
        <item>
            <title>Synopsis of investigations into proposed theories on the etiology of achalasia</title>
            <link>http://www.medworm.com/index.php?rid=3083587&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01030.x</link>
            <description>The current state of research into the etiology of achalasia only allows for speculation. To date, several studies have been performed investigating genetic, immune, and infectious disease mechanisms; however, none of these have been conclusive. Further research into this topic is warranted given the severity of the disease, and it may be possible that all of these mechanisms are involved in the pathophysiology of the disease. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3083587</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3083587</guid>        </item>
        <item>
            <title>Functional analysis of long-term outcome after Heller's myotomy for achalasia</title>
            <link>http://www.medworm.com/index.php?rid=3083586&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01031.x</link>
            <description>The objective was to analyze esophageal functional results after Heller myotomy in the long term. Results were classified as excellent, good, fair, or poor, according to Vantrappen and Hellemans' modified classification. One-year, 2-year, 5-year, 10-year, and 20-year postoperative follow-up information was available in 100% of all patients, 91.7%, 85.1%, 60%, 52.6%, and 45.9%, respectively. There were no perioperative deaths. One year after the surgery, all patients had a significant reduction in symptoms of dysphagia and regurgitation. Five years, 10 years, 15 years, and 20 years after surgery, there were 77.2% of patients (142 in 184), 68.1%, 57.1%, and 54.5%, respectively, who were satisfied (excellent to good) with surgery. No esophageal peristalsis was demonstrated in patients during ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3083586</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3083586</guid>        </item>
        <item>
            <title>Laparoscopic Heller myotomy with Dor fundoplication for achalasia: long-term outcomes and effect on chest pain</title>
            <link>http://www.medworm.com/index.php?rid=3083585&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01032.x</link>
            <description>The aim of the present study was to evaluate the long-term outcomes of laparoscopic Heller myotomy with Dor fundoplication (LHD) and its effect on chest pain. Between June 1995 and August 2009, a total of 35 patients with achalasia underwent an LHD. The symptom scores were calculated by combining the frequency and the severity. Pre- and postoperative evaluations included symptom score, radiology, manometry, and 24-hour pH manometry. Median total symptom score was significantly lower than the preoperative score (19 vs 4, P &lt; 0.001) at a median follow-up of 94 months. Among the 35 patients, 18 (51%) had chest pain. The frequency of chest pain was similar for the pre- and postoperative scores, but the severity tended to be less. Median esophageal diameter (5.4 cm vs 3.5 cm, P &lt; 0.001) and low...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3083585</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3083585</guid>        </item>
        <item>
            <title>Pilot translational study of dietary vitamin C supplementation in Barrett's esophagus</title>
            <link>http://www.medworm.com/index.php?rid=3020394&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01027.x</link>
            <description>The transcription factor Nuclear factor kappa B (NF-[kappa]B) is central to the regulation of genes encoding for mediators of inflammation and carcinogenesis. In the esophagus, NF-[kappa]B is progressively activated from inflammation to Barrett's metaplasia and adenocarcinoma. Vitamin C, an antioxidant, can inhibit NF-[kappa]B in in vitro models, and the aim of this study was to prospectively assess the effect of supplemental vitamin C on NF-[kappa]B and associated cytokines in patients with Barrett's esophagus. Twenty-five patients with long-segment Barrett's and specialized intestinal metaplasia received dietary vitamin C (1000 mg/day) orally for four weeks, and had pre- and post-vitamin C endoscopic biopsies. NF-[kappa]B activity (activated p50 and p65 subunits) of nuclear extracts was ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3020394</comments>
            <pubDate>Tue, 24 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3020394</guid>        </item>
        <item>
            <title>Posterior thoracic esophagostomy as an esophageal sparing procedure</title>
            <link>http://www.medworm.com/index.php?rid=3020397&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01024.x</link>
            <description>A diverting (posterior) thoracic esophagostomy is a rare, but acceptable, surgical option in some cases. The goal is to save as much esophageal length as possible with a view to future reconstructive surgery. We herein report a 41-year-old woman, in whom a posterior thoracic esophagostomy was successfully created and used for reestablishing further physiological alimentary continuity in a second stage. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3020397</comments>
            <pubDate>Mon, 23 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3020397</guid>        </item>
        <item>
            <title>Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery</title>
            <link>http://www.medworm.com/index.php?rid=3020396&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01025.x</link>
            <description>In conclusion, VATS shows an overall benefit on QOL for the patients with esophageal cancer during the follow-up of six month after esophagectomy, compared with open surgery. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3020396</comments>
            <pubDate>Mon, 23 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3020396</guid>        </item>
        <item>
            <title>Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions</title>
            <link>http://www.medworm.com/index.php?rid=3020395&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01026.x</link>
            <description>Squamous cell carcinoma of the esophagus (ESCC) has a poor prognosis among digestive tract cancers. Lymph node metastasis and distant metastasis are the major factors determining its prognosis. We used comparative genomic hybridization (CGH) to evaluate primary tumor lymph nodes and metastatic areas from ESCC patients in order to determine the relationship between abnormal chromosome regions and outcome. Tumor tissues and lymph nodes were collected from 51 patients with ESCC, and abnormal chromosome regions were detected by CGH. We searched for regions that were significantly more common in patients with lymph nodes metastases (n[ge] 6) or distant metastases, and correlated those chromosomal changes with survival. Regions showing amplification in more than 65% of esophageal squamous cell c...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3020395</comments>
            <pubDate>Mon, 23 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3020395</guid>        </item>
        <item>
            <title>Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection</title>
            <link>http://www.medworm.com/index.php?rid=2975143&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01023.x</link>
            <description>Endoscopic resection is curative for superficial esophageal squamous cell carcinoma (ESCC) limited to the lamina propria. Endoscopic resection is not recommended for superficial ESCC invading muscularis mucosa or submucosa, however, because of the high frequency of lymph node metastasis (LNM) in such patients. Methods to more accurately predict LNM by analysis of endoscopically resected specimens are needed. Patients with superficial ESCC who underwent surgery without prior chemoradiotherapy (n= 110) were retrospectively examined to determine whether LNM correlated with immunohistochemical parameters and conventional histological parameters, including depth of invasion and vascular permeation. Cancer cell expression of claudins-1, 5, and 7, E-cadherin, [beta]-catenin, and matrix metallopro...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2975143</comments>
            <pubDate>Tue, 10 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2975143</guid>        </item>
        <item>
            <title>The high incidence of esophageal cancer in parts of China may result primarily from genetic rather than environmental factors</title>
            <link>http://www.medworm.com/index.php?rid=2975146&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01020.x</link>
            <description>This study examined the impact of changing environments on esophageal cancer by comparing age-standardized mortality rates of immigrant group to the rates of native population (natives who live in high cancer location and have never moved) and host populations (hosts who live in low cancer location and have never moved people). All ESCC deaths taking place during 1999[ndash]2004 among the migrant, native, and host populations were identified by retrospective population-based screening. Direct age-adjusted mortality rates were calculated by using the China population of year 2000 as standard population. From 1999[ndash]2004, the average annual age-adjusted mortality of ESCC for the migrant, native, and host population was 61.6/100 000, 59.7/100 000, and 6.7/100 000, respectively. No decreas...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2975146</comments>
            <pubDate>Mon, 09 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2975146</guid>        </item>
        <item>
            <title>Inversed Y cardioplasty plus a truncal vagotomy-antrectomy and a Roux-en-Y gastrojejunostomy performed in patients with stricture of the esophagogastric junction after a failed cardiomyotomy or endoscopic procedure in patients with achalasia of the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2975145&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01021.x</link>
            <description>Laparoscopic anterior cardiomyotomy in addition to anterior Dor's fundoplication is the procedure of choice for achalasia of the esophagus with approximately 95% success rate. Redo cardiomyotomy is complicated and associated with rerecurrence of dysphagia. Twelve patients with failed redo myotomy were clinically evaluated with radiology, endoscopy, and manometry in whom achalasia type III or IV was confirmed. We propose as treatment for these selected cases an inversed Y cardioplasty + truncal vagotomy, a partial distal gastrectomy and Roux-en-Y gastrojejunostomy in order to facilitate esophageal emptying and avoid the appearance of postoperative gastroesophageal reflux as a side effect of this procedure. One patient was reoperated on in order to enlarge the cardioplasty. Disappearance of ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2975145</comments>
            <pubDate>Mon, 09 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2975145</guid>        </item>
        <item>
            <title>Use of endoscopy in diagnosis and management of patients with dysphagia in an African setting</title>
            <link>http://www.medworm.com/index.php?rid=2975144&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01022.x</link>
            <description>The objectives of this study were to define the utility of esophagogastroduodenoscopy in the diagnosis and management of patients presenting with dysphagia and to determine the relative incidence of the various causes of dysphagia in Sudan. This is a prospective, cross-sectional, descriptive, hospital-based study carried out at the endoscopy unit of Soba University Hospital, Khartoum, Sudan. All patients complaining of dysphagia underwent upper gastrointestinal endoscopy with therapeutic intervention when necessary. A total of 114 patients were enrolled in the study, with a mean age of 47 years SD ± 19 and a male to female ratio of 1 : 1.04. A benign condition was diagnosed in 56% of the cases; this included esophageal strictures in 21% of the cases and achalasia in 14%. Malignant causes ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2975144</comments>
            <pubDate>Mon, 09 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2975144</guid>        </item>
        <item>
            <title>Diagnosis of eosinophilic esophagitis after fundoplication for 'refractory reflux': implications for preoperative evaluation</title>
            <link>http://www.medworm.com/index.php?rid=2928754&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01019.x</link>
            <description>A small percentage of patients who carry the diagnosis of refractory gastroesophageal reflux disease (GERD) actually have eosinophilic esophagitis (EoE). The purpose of this study was to describe a series of patients who underwent fundoplication for presumed refractory GERD, but subsequently were found to have EoE. We performed a retrospective analysis of our EoE database. Patients diagnosed with EoE after Nissen were identified. Cases were defined according to recent consensus guidelines. Five patients underwent anti-reflux surgery for refractory GERD, but were subsequently diagnosed with EoE. None had esophageal biopsies prior to surgery, and in all subjects, symptoms persisted afterward, with no evidence of wrap failure. The diagnosis of EoE was typically delayed (range: 3[ndash]14 year...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928754</comments>
            <pubDate>Tue, 27 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2928754</guid>        </item>
        <item>
            <title>Chemoradiotherapy for cancer of the esophagus: contribution of the leucovorin, 5-fluorouracil bolus, and infusion&amp;#x2013;cisplatin&amp;#x2013;radiotherapy schedule starting with two neoadjuvant chemotherapy cycles: results from a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=2928757&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01016.x</link>
            <description>To assess feasibility and tolerance of a modification in the usual radiochemotherapy regimen for esophageal cancer by using a leucovorin, 5-fluorouracil bolus, and infusion[ndash]cisplatin regimen (six cycles), beginning with two cycles of chemotherapy before conventional radiotherapy (50 Gy), 33 patients, 30 were men, 62.8 ± 9.5 years, were treated for an esophageal carcinoma (29 squamous cell), 27 of these were in stage III (based on computed tomography scan). Neoadjuvant chemotherapy was well tolerated; concomitant radiochemotherapy was associated with severe adverse events mostly hematological in 23 patients. Complete response was achieved in 70%; median overall survival was 14 months, and 2-year survival was 40 ± 11%. More than one-third of cycles could be performed as outpatients. ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928757</comments>
            <pubDate>Mon, 26 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2928757</guid>        </item>
        <item>
            <title>Options in the management of esophageal perforation: analysis over a 12-year period</title>
            <link>http://www.medworm.com/index.php?rid=2928756&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01017.x</link>
            <description>Controversies exist about the management of esophageal perforation in order to eliminate the septic focus. The aim of this study was to assess the etiology, management, and outcome of esophageal perforation over a 12-year period, in order to characterize optimal treatment options in this severe disease. Between May 1996 and May 2008, 44 patients (30 men, 14 women; median age 67 years) with esophageal perforation were treated in our department. Etiology, diagnostic procedures, time interval between clinical presentation and treatment, therapeutic management, and outcome were analyzed retro- or prospectively for each patient. Iatrogenic injury was the most frequent cause of esophageal perforation (n= 28), followed by spontaneous (n= 9) and traumatic (n= 4) esophageal rupture (in three patien...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928756</comments>
            <pubDate>Mon, 26 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2928756</guid>        </item>
        <item>
            <title>Atypical esophageal vascular lesions observed in liver cirrhosis</title>
            <link>http://www.medworm.com/index.php?rid=2928755&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01018.x</link>
            <description>We report a case of esophageal vascular lesions resembling spider naevi in a patient with nonalcoholic cirrhosis who underwent an upper gastrointestinal (GI) endoscopy. We observed the presence of multiple white round elevations, 5[ndash]6 mm in size, with radiating thin-walled vessels, in the middle and distal esophagus. The histological examination documented the presence of multiple dilated blood vessels in the mucosal layer of the esophagus, with striking thickening of the endothelium wall. There was no evidence of esophagogastric varices, but only of a moderate congestive antral gastropathy. To our knowledge, these endoscopic esophageal findings have not yet been described in cirrhosis. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2928755</comments>
            <pubDate>Mon, 26 Oct 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2928755</guid>        </item>
        <item>
            <title>Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older</title>
            <link>http://www.medworm.com/index.php?rid=2833304&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01014.x</link>
            <description>In conclusion, elderly patients experienced substantial morbidity from chemoradiation, and long-term survival was low. Future efforts to improve treatment tolerability in the elderly are needed. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833304</comments>
            <pubDate>Fri, 25 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2833304</guid>        </item>
        <item>
            <title>Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=2833308&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01010.x</link>
            <description>In conclusion, perioperative administration of sivelestat sodium hydrate (starting at the beginning of surgery) mitigated postoperative hypoxia, partially suppressed postoperative hypercytokinemia, shortened the duration of SIRS, and stabilized postoperative circulatory status after thoracoscopic esophagectomy. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833308</comments>
            <pubDate>Thu, 24 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2833308</guid>        </item>
        <item>
            <title>A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=2833307&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01011.x</link>
            <description>The objectives of this study were the following: (i) to evaluate whether FCSEMS are useful in patients receiving neoadjuvant therapy; and (ii) to assess ease of removability and tissue reaction to FCSEMS. FCSEMS (ALIMAXX-E, Alveolus Inc) were deployed in consecutive patients with locally advanced esophageal cancer over a period of 14 months. All patients were referred for neoadjuvant chemoradiation therapy after stenting. Dysphagia scores were assessed at 0 month, 1 month, 3 months, and 6 months. Barium swallow and endoscopy were performed for new symptoms and follow-up. Eleven patients were treated with FCSEMS prior to neoadjuvant therapy (mean age 60.5 years, 55% white, 91% male). All but one stent were successfully placed. Strictures were located in the upper esophagus (n= 1), middle es...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833307</comments>
            <pubDate>Thu, 24 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2833307</guid>        </item>
        <item>
            <title>Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience</title>
            <link>http://www.medworm.com/index.php?rid=2833306&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01012.x</link>
            <description>The discrepancy between Eastern and Western countries exists regarding the time trends of Barrett's esophagus (BE)/adenocarcinoma. We aimed to elucidate this issue through a retrospective review of the endoscopic and pathological diagnoses of gastroesophageal reflux disease (GERD) over time in a Chinese population. All records were analyzed from 2000 to 2007. Records included demographic data, clinical indication for endoscopy, and endoscopic findings. The total number of endoscopic procedures increased over time. The indications for referral endoscopy secondary to GERD increased from 366 cases (4.9%) in the beginning of the study to 1439 cases (14.1%) at the end. Concomitant GERD symptoms did not significantly change (range, 13[ndash]15.1%) in screening endoscopic studies. Endoscopic dete...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833306</comments>
            <pubDate>Thu, 24 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2833306</guid>        </item>
        <item>
            <title>Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data</title>
            <link>http://www.medworm.com/index.php?rid=2833305&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01013.x</link>
            <description>In this study, expression of FOXP3 in ESCC tissue was evaluated in relation to the clinical data. Detection of FOXP3 mRNA was made by using quantitative real-time PCR while protein expression was assessed by immunocytochemistry (n = 112). The results were correlated to the clinical data including age, gender, carcinoma size, carcinoma differentiation, lymphatic invasion and pathological stage. A significantly higher FOXP3 expression in tumors was confirmed than in normal-appearing mucosa. The FOXP3 mRNA and protein expressions were higher in advanced stages (stage II B and III) than in early stages (stage I and stage II A). A significantly higher FOXP3 expression in tumors with lymph node metastasis was also confirmed than in those without lymph node metastasis. No significant correlation ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833305</comments>
            <pubDate>Thu, 24 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2833305</guid>        </item>
        <item>
            <title>Thoracic osteophyte: rare cause of esophageal perforation</title>
            <link>http://www.medworm.com/index.php?rid=2742711&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01009.x</link>
            <description>We report two cases of esophageal perforations caused by thoracic osteophytes and different management strategies leading to successful outcomes. An 80-year-old male presented with chest pain and dysphagia following a fall. On endoscopy, an esophageal perforation and foreign body was noted which was confirmed as a thoracic osteophyte on computed tomography scan. He was managed conservatively as he declined surgery. A 63-year-old male was admitted with dysphagia following a food bolus obstruction. Following esophagoscopy and dilatation, there was clinical and radiological evidence of perforation. During surgery, a thoracic osteophyte was identified as the cause of perforation. The perforation was closed in layers and the osteophyte was trimmed. Both patients recovered well. Thoracic osteoph...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742711</comments>
            <pubDate>Fri, 28 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742711</guid>        </item>
        <item>
            <title>Definitive concomitant chemoradiotherapy with docetaxel and cisplatin in squamous esopheageal carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2742717&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01003.x</link>
            <description>This study evaluated the docetaxel-based definitive concomitant chemoradiotherapy in patients with esophageal squamous cell carcinoma to determine its clinical response and overall survival. In this unicenter trail, we enrolled 59 patients with histologically proven squamous cell carcinoma in the esophagus between March 2004 and December 2007. All patients were staged II to IV and treated with definitive concomitant chemoradiotherapy. Radiotherapy was delivered with conventional fraction, 50[ndash]64 Gy in 25[ndash]35 fractions. Patients received two cycles of a 1-day regimen containing docetaxel (60 mg/m2) and cisplatin (80 mg/m2) every 3 weeks during the period of radiotherapy. The chemoradiotherapy was applied as planned in all patients and the median chemotherapy delay time was 6 days ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742717</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742717</guid>        </item>
        <item>
            <title>Multimodality treatment with intensity modulated radiation therapy for esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=2742716&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01004.x</link>
            <description>The objective of this study is to determine the feasibility and report the outcome of patients with locally advanced esophageal cancer treated with preoperative or definitive chemoradiotherapy (CRT) using intensity-modulated radiation therapy (IMRT). Between 2003 and 2007, 30 patients with non-cervical esophageal cancer received concurrent chemotherapy and IMRT at Stanford University. Eighteen patients were planned for definitive CRT and 12 were planned for preoperative CRT. All patients had computed tomography-based treatment planning and received IMRT. The median dose delivered was 50.4 Gy. Patients planned for preoperative CRT underwent surgery 4[ndash]13 weeks (median 8.3 weeks) following completion of CRT. Median follow-up of surviving patients from start of RT was 24.2 months (range ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742716</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742716</guid>        </item>
        <item>
            <title>Combined treatment of achalasia &amp;#x2013; botulinum toxin injection followed by pneumatic dilatation: long-term results</title>
            <link>http://www.medworm.com/index.php?rid=2742715&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01005.x</link>
            <description>Injection of botulinum toxin (BT) and pneumatic dilatation are available methods in nonsurgical treatment of achalasia. Authors anticipate beneficial effect of prior BT injection on the success of pneumatic dilatation and duration of its effect. There are no long-term data available to assess efficacy of combined treatment. From 1998 to 2007, 51 consecutive patients (20 men and 31 women, age 24[ndash]83) with achalasia were included and prospectively followed up. Each patient received injection of 200 IU of BT into the lower esophageal sphincter (LES) during endoscopy and 8 days later pneumatic dilatation (PD) under X-ray control was performed. The follow-up was established every 3 months first year and then annually. The efficacy was evaluated by a questionnaire concerning patient's sympt...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742715</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742715</guid>        </item>
        <item>
            <title>Clinical predictors of achalasia</title>
            <link>http://www.medworm.com/index.php?rid=2742714&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01006.x</link>
            <description>Limited access to esophageal manometry (EM) may delay identification and treatment of patients with achalasia. In order to assess predictors to fast-track patients for manometric confirmation of achalasia, we compared the clinical, radiographic, and endoscopic characteristics of achalasia patients to patients with functional dysphagia without manometric features of achalasia (controls). Patients referred for esophageal manometry to assess functional dysphagia prospectively identified over a 12-month period were asked to participate in this study. The Achalasia Symptom Questionnaire (ASQ), a structured 11-question survey (score: 0[ndash]best, 67[ndash]worst), was completed by all consenting patients. ASQ scores, esophago-gastro-duodenoscopy and upper gastro-intestinal (UGI) contrast study f...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742714</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742714</guid>        </item>
        <item>
            <title>Effect of glutamine in patients with esophagus resection</title>
            <link>http://www.medworm.com/index.php?rid=2742713&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01007.x</link>
            <description>This article aims to study the effects of glutamine on systemic inflammatory response, morbidity, and mortality after esophagectomy. A prospective, randomized, double-blind, and controlled trial was used. Following sealed-envelope block randomization, the patients were divided into two groups. Members of the glutamine group (group G) received glutamine (Dipeptiven, Fresenius) as continuous infusion for 6 hours at 0.5 g/kg for 3 days prior to, and 7 days following surgery; while patients of the control group were given placebo. We examined 30 patients in group G, and 25 patients as controls. In both patient groups, the levels of total protein, albumin, pre-albumin, retinol binding protein, transferrin, transferring-saturation, C-reactive protein, procalcitonin, lymphocte, Interleukin-6, Int...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742713</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742713</guid>        </item>
        <item>
            <title>Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus development</title>
            <link>http://www.medworm.com/index.php?rid=2742712&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01008.x</link>
            <description>Here we directly compared gene expression profiles in human esophageal squamous cell carcinomas and in human fetal esophagus development. We used the suppression subtractive hybridization technique to subtract cDNAs prepared from tumor and normal human esophageal samples. cDNA sequencing and reverse transcription polymerase chain reaction (RT-PCR) analysis of RNAs from human tumor and the normal esophagus revealed 10 differentially transcribed genes: CSTA, CRNN, CEACAM1, MAL, EMP1, ECRG2, and SPRR downregulated, and PLAUR, SFRP4, and secreted protein that is acidic and rich in cysteine upregulated in tumor tissue as compared with surrounding normal tissue. In turn, genes up- and downregulated in tumor tissue were down- and upregulated, respectively, during development from the fetal to adu...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2742712</comments>
            <pubDate>Thu, 27 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2742712</guid>        </item>
        <item>
            <title>High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome</title>
            <link>http://www.medworm.com/index.php?rid=2659162&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00999.x</link>
            <description>This study is a retrospective analysis of high-dose definitive concomitant chemoradiotherapy in locally advanced esophageal cancer in a single institution. The aim of the study was to identify and quantify the toxicity associated with the high-dose treatment and to analyze the outcome of this treatment. Forty-six patients (41 men and 5 women, median age of 67.5 years) with disease stage IIA[ndash]III esophageal cancer were treated with high-dose definitive chemoradiotherapy. Thirty patients had squamous cell carcinomas and 16 had adenocarcinomas. The patients were treated with three courses of chemotherapy. Each chemotherapy course consisted of cisplatin 100 mg/m2, day 1 and 5-Fluorouracil 1000 mg/m2/day, day 1[ndash]5. One course was given every 3 weeks. Concurrent radiotherapy (66 Gy/33 ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2659162</comments>
            <pubDate>Fri, 31 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2659162</guid>        </item>
        <item>
            <title>Esophageal manometry in 28 systemic sclerosis Brazilian patients: findings and correlations</title>
            <link>http://www.medworm.com/index.php?rid=2659166&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01000.x</link>
            <description>Systemic sclerosis (SSc) is a multisystem disease of unknown etiology. Esophageal involvement affects 50[ndash]90% of patients and is characterized by abnormal motility and hypotonic lower esophageal sphincter. Data on the association of esophageal abnormalities and age, gender, SSc subset or duration, autoantibody profile, esophageal symptoms, and medication are lacking or conflicting. The aim of this study was the evaluation of these associations in Brazilian sclerodermic patients from the Rheumatology Division, Clinics Hospital, Federal University, Minas Gerais. They underwent medical records review, clinical interview, and esophageal manometry. The normal cutoff level for lower esophageal sphincter pressure was 14 mmHg. Abnormal peristalsis occurred when less than 80% of peristaltic wa...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2659166</comments>
            <pubDate>Thu, 30 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2659166</guid>        </item>
        <item>
            <title>Comparative proteomic analysis of &amp;#x03B2;-catenin-mediated malignant progression of esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2659165&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.01001.x</link>
            <description>[beta][ndash]catenin has emerged as a key regulator of Wnt signaling pathway, which plays an important role in the development and progression of various cancers. Its accumulation in nucleus of the esophagus squamous epithelium might be the crucial step for the carcinogenesis of esophageal squamous cell carcinoma (ESCC). To detect the proteins correlated with [beta][ndash]catenin function, we used the established cell lines of pGen-3-con (Eca109 cells transfected by control vector) and pGen-3-CTNNB1 (Eca109 cells transfected by [beta]-catenin siRNA) as cell models for further analysis. Two-dimensional gel electrophoresis technology was performed to separate the proteins of pGen-3-con and pGen-3-CTNNB1 cell lines, respectively. The differential protein spots were analyzed by software analys...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2659165</comments>
            <pubDate>Thu, 30 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2659165</guid>        </item>
        <item>
            <title>Palliative radiation therapy practice for advanced esophageal carcinoma in Africa</title>
            <link>http://www.medworm.com/index.php?rid=2659164&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00997.x</link>
            <description>While numerous surveys of pattern of practices of palliative radiotherapy (RT) in advanced esophageal cancers have been published in developed countries, there is no such survey in African countries. During and after a regional training course by the International Atomic Energy Agency (IAEA) in palliative cancer care, a questionnaire was distributed to African RT centers to gather information about infrastructure and human resources available, and the pattern of practice of palliative RT for esophageal cancers. Twenty-four of the 35 centers (60%) completed the questionnaire. Twenty out of 23 (87%) centers treat patients with esophageal cancer presenting with dysphagia using external beam RT (16 centers external beam RT alone and 4 centers also use brachytherapy as a boost). Twelve (60%) ce...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2659164</comments>
            <pubDate>Thu, 30 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2659164</guid>        </item>
        <item>
            <title>Reflux esophagitis and columnar-lined esophagus after cervical esophagogastrostomy (following esophagectomy)</title>
            <link>http://www.medworm.com/index.php?rid=2659163&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00998.x</link>
            <description>Reflux esophagitis (RE) and columnar-lined esophagus (CLE) are frequently observed after esophagectomy. The incidence of these conditions according to time and to the route of esophageal reconstruction after esophagectomy remains unknown. The aim of this study was to clarify any changes and differences of the incidence of RE and CLE in patients who underwent gastric tube reconstruction after esophagectomy. A hundred patients who underwent cervical esophagogastrostomy after resection of the thoracic esophagus were included in this study. We reviewed their endoscopic findings at 1 month, at 1 year and at 2 years after surgery, and compared the incidence rates of RE and CLE with the passage of time and among the three reconstruction routes; a subcutaneous route, a retrosternal route, and a po...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2659163</comments>
            <pubDate>Thu, 30 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2659163</guid>        </item>
        <item>
            <title>Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2490177&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00979.x</link>
            <description>Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5), a recently discovered intestinal stem cell marker, is expressed in premalignant lesions including Barrett's esophagus (BE) and cancers including colon cancer, ovarian cancer, and hepatocellular carcinoma. It was also recently found to be expressed in tumor spheres prepared from colon cancer, suggesting that it will likely serve as a cancer stem cell marker. We sought to examine Lgr5 as a biomarker in BE-associated neoplasia. Using standard immunohistochemistry, we performed immunostaining on 81 esophageal specimens (53 biopsy specimens and 28 surgical resections) representing BE, BE-associated dysplasia, and esophageal adenocarcinoma (EAC). Each immunostain was scored based on intensity of immunostaining and percentage of ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490177</comments>
            <pubDate>Sun, 21 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2490177</guid>        </item>
        <item>
            <title>Effectiveness of voice therapy in reflux-related voice disorders</title>
            <link>http://www.medworm.com/index.php?rid=2490176&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00992.x</link>
            <description>Gastroesophageal reflux (GER) with laryngopharyngeal reflux plays a significant role in voice disorders. A significant proportion of patients attending ear, nose, and throat clinics with voice disorders may have gastresophageal reflux disease (GERD). There is no controlled study of the effect of voice therapy on GERD. We assessed the effect of voice therapy in patients with dysphonia and GERD. Thirty-two patients with dysphonia and GERD underwent indirect laryngoscopy and voice analysis. Esophageal and laryngeal symptoms were assessed using the reflux symptom index (RSI). At endoscopy, esophagitis was graded according to Los Angeles classification. Patients were randomized to receive either voice therapy and omeprazole (20 mg bid) (n = 16, mean [SD] age 36.1 [9.6] y; 5 men; Gp A) or omepra...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490176</comments>
            <pubDate>Sun, 21 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2490176</guid>        </item>
        <item>
            <title>Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells</title>
            <link>http://www.medworm.com/index.php?rid=2490175&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00993.x</link>
            <description>In conclusion, treatment of BE cells with acidified medium and a bile acid cocktail at physiologically relevant concentrations induces DNA damage, cytotoxicity, and ROS. The cytoprotective bile acid, GUDCA, inhibits these deleterious effects by inhibiting oxidative stress. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490175</comments>
            <pubDate>Sun, 21 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2490175</guid>        </item>
        <item>
            <title>Endoscopic classification for reflux pharyngolaryngitis</title>
            <link>http://www.medworm.com/index.php?rid=2490174&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00994.x</link>
            <description>The quality of life in patients who have undergone surgery for esophageal cancer is frequently disturbed by postoperative gastroesophageal reflux disease or pharyngolaryngeal reflux disease. Recently, there have been many reports on gastroesophageal reflux disease after esophagectomy, and only a few on pharyngolaryngeal reflux disease. There is not yet any convenient endoscopic classification of reflux pharyngolaryngitis. We designed a new classification for reflux pharyngolaryngitis based on endoscopic findings. Our new classification consists of the five grades from 0 to IV based on (i) the extent and severity of erythema and/or edema in the pharynx and the larynx, and (ii) the extent and severity of granulation or scarring stenosis in the vocal cords. Ninety-three patients after cervica...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490174</comments>
            <pubDate>Sun, 21 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2490174</guid>        </item>
        <item>
            <title>Prevalence and outcome of esophagogastric anastomotic leak after esophagectomy in a UK regional cancer network</title>
            <link>http://www.medworm.com/index.php?rid=2490173&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00995.x</link>
            <description>The aim of this study was to determine the contemporary prevalence, outcome, and survival after esophagogastric anastomotic leakage (EGAL) following esophagectomy by a regional upper gastrointestinal cancer network and to investigate etiological factors. Two hundred forty consecutive patients underwent esophagectomy over a 10-year period (median age 61 [31[ndash]79] years, 147 transthoracic and 93 transhiatal esophagectomy, 105 neoadjuvant chemotherapy, 49 chemoradiotherapy). The primary outcome measures were the development of EGAL and survival. Twenty patients developed EGAL (8.3%, 15 managed conservatively, 5 reoperation). Overall operative mortality was 2% (5 patients in total, 1 after EGAL). Median, 1 and 2-year survival was 22 months, 73% and 50%, in patients after EGAL, compared wit...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490173</comments>
            <pubDate>Sun, 21 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2490173</guid>        </item>
        <item>
            <title>Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2470559&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00991.x</link>
            <description>The objective of this study is to characterize safety, tolerability, and efficacy of low-pressure liquid nitrogen endoscopic spray cryotherapy ablation in a large cohort across multiple study sites. Parallel prospective treatment studies at four tertiary care academic medical centers in the U.S. assessed spray cryotherapy in patients with Barrett's esophagus with or without dysplasia, early stage esophageal cancer, and severe squamous dysplasia who underwent cryotherapy ablation of the esophagus. All patients were contacted between 1 and 10 days after treatment to assess for side effects and complications of treatment. The main outcome measurement was the incidence of serious adverse events and side effects from treatment. Complete response for high-grade dysplasia (HGD) (CR-HGD), all dysp...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470559</comments>
            <pubDate>Thu, 11 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470559</guid>        </item>
        <item>
            <title>Medium-term outcome of fundoplication after lung transplantation</title>
            <link>http://www.medworm.com/index.php?rid=2470570&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00980.x</link>
            <description>Gastroesophageal reflux disease (GERD) in lung transplant recipients has gained increasing attention as a factor in allograft failure. There are few data on the impact of fundoplication on survival or lung function, and less on its effect on symptoms or quality of life. Patients undergoing fundoplication following lung transplantation from 1999 to 2005 were included in the study. Patient satisfaction, changes in GERD symptoms, and the presence of known side effects were assessed. The effect on lung function, body mass index, and rate of progression to the bronchiolitis obliterans syndrome (BOS) were recorded. Twenty-one patients (13 males), in whom reflux was confirmed on objective criteria, were included, with a mean age of 43 years (range 20[ndash]68). Time between transplantation and fu...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470570</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470570</guid>        </item>
        <item>
            <title>Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases</title>
            <link>http://www.medworm.com/index.php?rid=2470569&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00981.x</link>
            <description>This study mainly retrospectively analyzed clinicopathological and immunohistochemical features of 15 cases of superficial PESCC in our hospital from 1990 to 2004, in order to find suitable diagnostic markers and applicable therapies for this disease. The records mainly included presenting symptoms, demographics, diagnostic method, histopathology, follow[ndash]up, and therapy. Immunohistochemical staining of chromogranin A (CgA), neuron-specific enolase (NSE), synaptophysin (Syn), neuronal cell adhesion molecules (CD56), thyroid transcription factor-1 (TTF-1), cytokeration 34[beta]E12 (CK34[beta]E12), cytokeratin (AE1/AE3), and cytokeratin 10/13 was performed. Incidence of superficial PESCC accounted for 4.8% of that of superficial carcinoma of the esophagus during the same period. Initial...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470569</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470569</guid>        </item>
        <item>
            <title>Barrett's esophagus and endoscopically assessed esophagogastric junction integrity in 1000 consecutive Turkish patients undergoing endoscopy: a prospective study</title>
            <link>http://www.medworm.com/index.php?rid=2470568&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00982.x</link>
            <description>Barrett's esophagus (BE) appears to be more common in Western than in Asian countries. BE is a complication of gastroesophageal reflux disease (GERD). Anatomical abnormalities of the esophagogastric junction (EGJ) are an important factor in the pathogenesis of GERD. We aimed to determine the prevalence of BE in Turkey, which is geographically located between Europe and Asia, and to investigate the frequency of BE according to the degree of anatomical disruption in the EGJ. This prospective study was performed on 1000 consecutive patients referred for endoscopy for any clinical indication. All patients underwent a structured interview that assessed major symptoms of GERD (regurgitation and heartburn). BE was diagnosed when specialized intestinal metaplasia was detected histologically in the...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470568</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470568</guid>        </item>
        <item>
            <title>Influence of psychopathological changes on quality of life after laparoscopic fundoplication for the treatment of gastroesophageal reflux</title>
            <link>http://www.medworm.com/index.php?rid=2470567&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00983.x</link>
            <description>The objective of this study is to analyze the influence of psychological changes, as assessed by the General Health Questionnaire-28 (GHQ-28), on patients undergoing surgery for gastroesophageal reflux. This is a prospective study in a series of 103 consecutive patients (62 males and 41 females with a mean age of 40 years) undergoing laparoscopic fundoplication. In addition to functional studies, patients completed the SF-36, Gastrointestinal Quality of Life Index, and GHQ-28 before surgery. Functional tests and questionnaires were repeated 6 months after surgery. Patients were also questioned about their degree of satisfaction. Postoperative results of patients with a normal GHQ-28 and patients showing psychopathological changes as defined by the GHQ-28 questionnaire before surgery were c...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470567</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470567</guid>        </item>
        <item>
            <title>Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up</title>
            <link>http://www.medworm.com/index.php?rid=2470566&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00984.x</link>
            <description>This study confirmed improved prognosis of patients after achieving negativity of nodes. Distant metastases prevailed as cause of the treatment failure. Prospectively, it is important to look for a therapeutic combination with better systemic effect. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470566</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470566</guid>        </item>
        <item>
            <title>Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons</title>
            <link>http://www.medworm.com/index.php?rid=2470565&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00985.x</link>
            <description>Controversy exists regarding optimal treatment practices for esophageal cancer. Esophagectomy has received focus as one of the index procedures for both hospital and surgical quality despite a relative paucity of controlled trials to define best practices. A survey was created to determine the degree of heterogeneity in the treatment of esophageal cancer among a diverse group of surgeons and to use high-volume (HV) ([ge]15 cases/year) and low-volume (LV) ( (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470565</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470565</guid>        </item>
        <item>
            <title>Esophagectomy for cancer: clinical concerns support centralizing operations within the larger hospitals</title>
            <link>http://www.medworm.com/index.php?rid=2470564&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00986.x</link>
            <description>Esophagectomy needs experienced surgical techniques and a well-trained perioperative care team. There are now many reports that the mortality rate after esophagectomy is higher in those hospitals with a low volume of esophagectomy and/or low surgeon's volume. The purpose of this study is to decide the respective numbers of esophagectomy operations per year to define low-volume and high-volume hospitals in Japan. If medical policy aims to further reduce mortality and morbidity associated with esophagectomy, then esophagectomy operations should be further centralized, away from low-volume hospitals, into high-volume hospitals. The Japanese Association for Thoracic Surgery has accumulated the surgical outcomes from 31 380 esophagectomy operations, registered from 709 institutes during the per...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470564</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470564</guid>        </item>
        <item>
            <title>Is esophagoscopy necessary for corrosive ingestion in adults?</title>
            <link>http://www.medworm.com/index.php?rid=2470563&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00987.x</link>
            <description>The aim of the study was to determine whether early esophagoscopy is really necessary for the patients who have ingested a corrosive agent. Patients who were followed up with the diagnosis of corrosive ingestion in our clinic between the years 1998 and 2008 were studied retrospectively. The data were collected through the medical records of the patients and from interviews with them. The analyzed parameters included age, gender, the nature and the amount of the ingested agent, whether the event was accidental or suicidal, diagnostic tools, treatment and the results of the treatment, and long-term follow up. Over a 10-year period, a total of 124 cases of corrosive ingestion cases were determined. Of these, 64 (51.6%) were male and 60 (48.4%) were female. The mean age was 38 ± 17.5 years. T...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470563</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470563</guid>        </item>
        <item>
            <title>Does combined multichannel intraluminal esophageal impedance and manometry predict postoperative dysphagia after laparoscopic Nissen fundoplication?</title>
            <link>http://www.medworm.com/index.php?rid=2470562&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00988.x</link>
            <description>Laparoscopic Nissen fundoplication (LNF) is an effective treatment for gastroesophageal reflux disease; however, some patients develop dysphagia postoperatively. Manometry is used to evaluate disorders of peristalsis, but has not been proven useful to identify which patients may be at risk for postoperative dysphagia. Multichannel intraluminal impedance (MII) evaluates the effective clearance of a swallowed bolus through the esophagus. We hypothesized that MII combined with manometry may detect those patients most at risk of developing dysphagia after LNF. Between March 2003 and January 2007, 74 patients who agreed to participate in this study were prospectively enrolled. All patients completed a preoperative symptom questionnaire, MII/manometry, and 24-h pH monitoring. All patients underw...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470562</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470562</guid>        </item>
        <item>
            <title>Assessment of response to neoadjuvant therapy in esophageal cancer: an updated systematic review of diagnostic accuracy of endoscopic ultrasonography and fluorodeoxyglucose positron emission tomography</title>
            <link>http://www.medworm.com/index.php?rid=2470561&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00989.x</link>
            <description>For assessing response to neoadjuvant therapy in patients with esophageal cancer, both endoscopic ultrasonography (EUS) and fluorodeoxyglucose positron emission tomography (FDG-PET) are commonly used, and despite few controlled trials, it is not known if one imaging modality is superior to the other. Also, relative diagnostic accuracy of early (during the course of neoadjuvant therapy) and FDG-PET after completion of neoadjuvant therapy has not been reviewed. The aim of this study was to perform a systematic review of published information to compare diagnostic accuracy of EUS and FDG-PET in this setting. A search of the MEDLINE, EMBASE, and Cochrane databases was performed along with a manual search of cross-references of eligible articles. Data on the accuracy of the imaging modalities w...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470561</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470561</guid>        </item>
        <item>
            <title>The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic</title>
            <link>http://www.medworm.com/index.php?rid=2470560&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00990.x</link>
            <description>The management of esophageal cancer with involvement of celiac lymph nodes is controversial. The purpose of this retrospective study was to evaluate the clinical importance of metastases to celiac lymph nodes in patients with carcinoma of the distal esophagus or gastroesophageal junction (GEJ) who undergo surgical treatment with curative intent. We reviewed the medical records of 310 patients who underwent definitive esophagectomy at the Mayo Clinic, Rochester, Minnesota, between 1976 and 1999 for carcinoma of the distal esophagus or GEJ. The disease location was distal esophagus in 163 and GEJ in 147. Fifty-two patients (17%) were found to have celiac node involvement. The survival of these patients was compared with that of 97 N0 patients and 161 N1 patients without celiac node involveme...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2470560</comments>
            <pubDate>Tue, 09 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2470560</guid>        </item>
        <item>
            <title>The use of self-expandable metallic stents for palliative treatment of inoperable esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=2419218&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00978.x</link>
            <description>In this study, the aim was to evaluate retrospectively the effectiveness of metallic stents deployed because of inoperable malignant esophageal stenosis and esophagotracheal fistulas. The results of 170 patients with 202 stents administered because of inoperable malignant esophageal stenosis and esophagorespiratory fistula between January 2000 and October 2008 at the Ataturk University, Department of Thoracic Surgery, were investigated. Despite epidemiological and clinical data, information regarding relief of dysphagia and quality of life were also examined. One hundred seventy patients with stents were between 28 and 91 years old (mean age 63.7 years ± 11.4 years). Ninety-seven were male and 73 were female. Stent indications were advanced tumors with distant metastasis (82 cases, 48.2%)...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419218</comments>
            <pubDate>Tue, 19 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2419218</guid>        </item>
        <item>
            <title>Contribution of germ line BRCA2 sequence alterations to risk of familial esophageal cancer in a high-risk area of India</title>
            <link>http://www.medworm.com/index.php?rid=2419221&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00975.x</link>
            <description>The incidence of esophageal squamous cell carcinoma (ESCC) is very high in the northeast region of India. An earlier study from China and Iran suggested that mutations in BRCA2 gene may play a role in the etiology of familial ESCC. However, the frequency of BRCA2 gene germ line mutations and its contribution to risk of familial aggregation of ESCC in high-risk region of India are not known. In the current study of 317 cases of esophageal cancer, 92 (29%) cases had a family history of esophageal and/or other cancers. Of these 92 patients, 45 (49%) patients had a family history of esophageal cancer. The risk of developing esophageal cancer was higher in cases where family history showed occurrence of cancers in first-degree relatives (odds ratio [OR]: 3.1; confidence interval [CI]: 1.9[ndash...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419221</comments>
            <pubDate>Fri, 15 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2419221</guid>        </item>
        <item>
            <title>Clinical manifestation of esophageal carcinosarcoma: a Taiwan experience</title>
            <link>http://www.medworm.com/index.php?rid=2419220&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00976.x</link>
            <description>This study aimed to investigate its clinicopathologic features and endoscopic characteristics. The data of patients diagnosed to have esophageal carcinosarcoma pathologically in the past 30 years (January 1976[ndash]December 2007) were reviewed. Of 3318 cases of esophageal malignancy, 12 were diagnosed as esophageal carcinosarcoma, with an incidence of 0.36%. All of the cases were male with a mean age of 62.3 years. Of the 12 tumors, 8 were polypoid type, and 4 were ulcerative type. In the endoscopic ultrasonography examination, the tumors show heterogeneous hypoechoic lesions with irregular outer margins and internal multicystic components. Four patients (33.3%) had previous head and neck squamous cell carcinoma that occurred metachronously. This is the first report about the characterist...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419220</comments>
            <pubDate>Fri, 15 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2419220</guid>        </item>
        <item>
            <title>Frequent occurrence of esophageal cancer in young people in western Kenya</title>
            <link>http://www.medworm.com/index.php?rid=2419219&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00977.x</link>
            <description>Esophageal cancer has a strikingly uneven geographical distribution, resulting in focal endemic areas in several countries. One such endemic area is in western Kenya. We conducted a retrospective review of all pathology-confirmed malignancies diagnosed at Tenwek Hospital, Bomet District, between January 1999 and September 2007. Tumor site, histology, sex, age, ethnicity, and location of residence were recorded. Cases were analyzed within and outside a traditional catchment area defined as [le]50 km from the hospital. Since 1999, the five most common cancer sites were the esophagus, stomach, prostate, colorectum, and cervix. Esophageal cancer accounted for 914 (34.6%) of the 2643 newly diagnosed cancers and showed increasing trends within and outside the catchment area. Fifty-eight (6.3%) p...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419219</comments>
            <pubDate>Fri, 15 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2419219</guid>        </item>
        <item>
            <title>Salvage esophagectomy after definitive chemoradiotherapy for synchronous double cancers of the esophagus and head-and-neck</title>
            <link>http://www.medworm.com/index.php?rid=2333783&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00973.x</link>
            <description>Head-and-neck cancer is frequently associated with esophageal cancer. Because the operative procedures for these synchronous double cancers are too invasive, definitive chemoradiotherapy tends to be applied as an initial treatment. A salvage esophagectomy for either recurrent or residual disease after definitive chemoradiotherapy in patients with such double cancer has never been reported. We reviewed 21 patients with esophageal cancer who underwent a salvage esophagectomy after definitive chemoradiotherapy. Among them, the treatment course of five patients who underwent a salvage esophagectomy for patients with synchronous double cancers of the esophagus and head-and-neck region was analyzed. Because head-and-neck cancer was well controlled after chemoradiotherapy in all five patients, a ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333783</comments>
            <pubDate>Fri, 17 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333783</guid>        </item>
        <item>
            <title>Application of a modified McKeown procedure (thoracoscopic esophageal mobilization three-incision esophagectomy) in esophageal cancer surgery: Initial experience with 30 cases</title>
            <link>http://www.medworm.com/index.php?rid=2333793&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00963.x</link>
            <description>Early efforts with minimally invasive esophagectomy (MIE) were hybrid approaches. No conclusive benefit was seen with this approach compared with the standard open procedure. Total MIE has demonstrated its advantages in single institution series. The drawbacks of total MIE include the steep learning curve and the high cost of the disposable instrumentation. We sought to determine the feasibility of modifying the surgical technique involved in the hybrid approach in an effort to decrease the cost of the surgery without compromising the outcome. From December 2007 to September 2008, the modified McKeown procedure (thoracoscopic esophageal mobilization three-incision esophagectomy) was performed in 30 cases. The median operative time was 225 minutes (range, 195 [minus]290 minutes) and the med...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333793</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333793</guid>        </item>
        <item>
            <title>Prognostic significance of perigastric lymph nodes metastases on survival in patients with thoracic esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=2333792&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00964.x</link>
            <description>Several publications have showed that the number of metastatic lymph node (LN) should be taken into consideration in nodal category of esophageal cancer, but seldom considered extent of involved regional LNs. The aim of this study is to evaluate the significance of the extent of regional LN metastasis on survival in patients with esophageal cancer. A total of 245 thoracic esophageal cancer patients underwent transthoracic esophagectomy with standard lymphadenectomy between January 2000 and December 2006 were included in the study. Data including demographic factors, pathologic findings, LN parameters and survival outcomes were collected. The survival experience was depicted using Kaplan-Meier method. A multivariate Cox proportional hazard model was used to screen the significant prognostic...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333792</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333792</guid>        </item>
        <item>
            <title>Polymorphisms of HLA-A and HLA-B genes in genetic susceptibility to esophageal carcinoma in Chaoshan Han Chinese</title>
            <link>http://www.medworm.com/index.php?rid=2333791&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00965.x</link>
            <description>Esophageal carcinoma (EC) occurs at high rate in Chaoshan region of southern China. Human leukocyte antigen (HLA) polymorphism has been implicated in risk for various cancers. To investigate the impact of HLA-A and HLA-B polymorphisms on susceptibility to EC, a case[ndash]control study was conducted among 206 patients with esophageal squamous cell carcinoma and 524 controls from Chaoshan Han population. HLA-A and HLA-B polymorphisms were genotyped by polymerase chain reaction-sequence-specific primers. Genotypic association tests for dominant, recessive, and additive models, and haplotypic association were calculated using unconditional logistic regression. A*11 was identified in a recessive model as an only allele strongly associated with EC risk (odds ratios [OR]= 2.10, 95% confidence in...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333791</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333791</guid>        </item>
        <item>
            <title>Esophageal pH exposure and epithelial cell differentiation</title>
            <link>http://www.medworm.com/index.php?rid=2333790&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00966.x</link>
            <description>It is proposed that epithelial changes induced by gastroesophageal reflux disease are related to the pH environment of the esophageal lumen. We hypothesized that the various types of esophageal epithelium are associated with specific pH environments that induce their formation. The aim of this study was to compare the luminal pH environment to the histology of the distal esophageal epithelium in patients with gastroesophageal reflux disease. A total of 197 symptomatic patients with increased esophageal acid exposure on 24-hour pH monitoring were grouped according to the histology based on biopsies from the distal esophagus: 17 with squamous epithelium, 126 with cardiac epithelium (CE), and 54 with Barrett's epithelium (BE). All were free of Helicobacter pylori infection and monitored off a...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333790</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333790</guid>        </item>
        <item>
            <title>The association between body mass index and Barrett's esophagus: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=2333789&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00967.x</link>
            <description>Biological plausibility and evidence from case series indicate that an increased body mass index could be a risk factor for Barrett's esophagus. The aim of this study was to assemble and appraise the available evidence on the association of body mass index and Barrett's esophagus in a narrative approach. A systematic literature review identified a nested case-control study and 10 case-control studies, with sample sizes of between 129 and 953. Overall, cases were on average older than controls, more often male and white, but did not differ with regards to body mass index. An increased body mass index ([ge]30 and [ge]35 kg/m2) was associated with greater risk of Barrett's esophagus in four studies (odds ratio range: 2.0[minus]4.0). These studies, however, did not adjust for symptoms suggesti...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333789</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333789</guid>        </item>
        <item>
            <title>Entrapment of a nasopharyngeal temperature probe: an unusual complication during an apparently uneventful elective revision laparoscopic nissen fundoplication</title>
            <link>http://www.medworm.com/index.php?rid=2333788&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00968.x</link>
            <description>We report the first case of nasopharyngeal temperature probe entrapment during an apparently uneventful elective revision laparoscopic Nissen fundoplication that precipitated a continuous quality improvement project at our institution. We describe changes in our clinical practice that resulted from this occurrence and envision these modifications will have a positive influence on patient care. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333788</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333788</guid>        </item>
        <item>
            <title>Building a bioresource for esophageal research: lessons from the early experience of an academic medical center</title>
            <link>http://www.medworm.com/index.php?rid=2333787&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00969.x</link>
            <description>We present herein the experience of an academic medical center in establishing a repository for esophageal research, with discussion of elements to be considered when establishing such a resource, from the quality assurance of samples to the organized collection and storage of associated clinical data. The development of this biorepository required significant planning to identify and consent participants by dedicated clinical and research personnel. Ensuring the quality of any biobank is of utmost importance, and one must understand the sample variability that exists during the acquisition of biospecimens. The time and type of fixative have been optimized in our unit by standard operating protocols. Methods for biomolecule extraction were tested by examining both the quality and the quant...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333787</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333787</guid>        </item>
        <item>
            <title>Systematic approach of postoperative gastric conduit complications after esophageal resection</title>
            <link>http://www.medworm.com/index.php?rid=2333786&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00970.x</link>
            <description>Complications after esophagectomy related to ischemia of the graft are dreaded. Prompt assessment of the situation is essential. The series presented describes our experience regarding the evaluation of gastric tube complications. A score is presented classifying flexible endoscopy and CT-scan findings. A retrospective analysis from the charts of 47 consecutive patients who underwent esophagectomy for cancer was conducted. Patients who underwent upper endoscopy during admittance were entered in this study. Findings on flexible endoscopy and CT scan were systematic scored. According to the findings, different attitudes were taken. Between January 2006 and December 2007, 47 patients underwent esophagectomy for cancer. Eleven (23%) out of 47 patients were suspected to have complications relat...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333786</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333786</guid>        </item>
        <item>
            <title>The number of lymph node metastases influences survival and International Union Against Cancer tumor&amp;#x2013;node&amp;#x2013;metastasis classification for esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2333785&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00971.x</link>
            <description>To study the influence of the number of metastatic lymph nodes (LNs) on survival and International Union Against Cancer tumor[ndash]node[ndash]metastasis (TNM) classification for esophageal carcinoma. The clinicopathological data on 1146 patients with esophageal squamous cell carcinoma who had undergone an esophagectomy were retrospectively studied. Survival was analyzed by the Kaplan[ndash]Meier method. By subclassifying the nodes (N) category according to the number of metastatic LNs as: N0 for no LN metastases; N1(1) for only one positive node; and N1(2) for [ge]2 positive nodes. TNM staging was refined as stage IIa (T2-3N0M0), stage IIb (T1N1M0 and T2N1(1)M0), stage IIIa (T2N1(2)M0 and T3N1(1)M0), and stage IIIb (T3N1(2)M0 and T4NanyM0), and the survival was analyzed. LN metastases was...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333785</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333785</guid>        </item>
        <item>
            <title>Drug-induced esophagitis</title>
            <link>http://www.medworm.com/index.php?rid=2333784&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00972.x</link>
            <description>is being recognized increasingly in the past few years. Since 1970 more than 650 cases have been reported worldwide caused by 30 or more medications. We have reviewed these cases with a view to classifying this disease based on underlying pathological mechanism. Drug-induced esophageal injury tends to occur at the anatomical site of narrowing, with the middle third behind the left atrium predominating (75.6%). The disease is broadly classified into two groups. The first group being transient and self-limiting as exemplified by the tetracycline group induced injury (65.8%). The second is the persistent esophagitis group, often with stricture, with two distinct entities: (i) patients on nonsteroidal anti-inflammatory agents whose injury is aggravated by gastroesophageal reflux (21.8%) (refl...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2333784</comments>
            <pubDate>Wed, 15 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2333784</guid>        </item>
        <item>
            <title>Nonspecific esophageal motility disorders may be an early stage of a specific disorder, particularly achalasia</title>
            <link>http://www.medworm.com/index.php?rid=2277439&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00962.x</link>
            <description>The clinical significance of nonspecific esophageal motility disorder (NEMD) is unclear. Our aim was to investigate the natural history of NEMD. All manometries performed at Meir Hospital from 1997 to 2004 and diagnosed as NEMD were reviewed. Manometric criteria for NEMD included either low-amplitude peristalsis, nonprogression of peristalsis, prolonged retrograde or triple-peaked waves, or incomplete relaxation of the lower sphincter. Patients determined to have NEMD were contacted and asked to complete a questionnaire and undergo a second manometry. NEMD had been diagnosed in 137 patients. Upon review of manometry results, 65 patients were eligible for the study (36 men and 29 women). The other 72 patients did not have NEMD when we reviewed their manometry tracing, applying strict criter...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277439</comments>
            <pubDate>Fri, 20 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277439</guid>        </item>
        <item>
            <title>Salvage esophagectomy after exclusive chemoradiotherapy: results at the Brazilian National Cancer Institute (INCA)</title>
            <link>http://www.medworm.com/index.php?rid=2277446&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00955.x</link>
            <description>In this study, 15 patients with esophageal cancer submitted to salvage esophagectomy after exclusive chemoradiotherapy treatment were retrospectively analyzed. Salvage esophagectomy was demonstrated to be technically feasible. However, it presents with high surgical morbidity. Currently, salvage esophagectomy is considered the best available treatment to attempt cure in cases of tumor recurrence or persistence after exclusive chemoradiotherapy. All the other types of treatments are regarded as palliative with discouraging survival results. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277446</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277446</guid>        </item>
        <item>
            <title>When did the esophagus start shrinking? The history of the short esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2277445&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00956.x</link>
            <description>Even though the history of this condition extends for almost 100 years, the short esophagus (SE) is still one of the most controversial topics in esophageal surgery with its existence still denied by some distinguished surgeons. We reviewed the evolution behind the diagnosis and treatment of the SE and the persons who wrote its history, from the first descriptions by radiologists, endoscopists, and surgeons to modern treatment. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277445</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277445</guid>        </item>
        <item>
            <title>HIF-1&amp;#x03B1; protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia</title>
            <link>http://www.medworm.com/index.php?rid=2277444&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00957.x</link>
            <description>We examined the protein expression of HIF-1[alpha] within the progression of Barrett's sequence as well as the type and degree of the environmental inflammatory reaction. Squamous epithelium (SE), metaplastic, low- and high-grade dysplastic lesions, and tumor tissue of 57 resection specimens from patients with Barrett's adenocarcinoma were immunohistochemically analyzed. Active and chronic inflammatory reactions were classified according to the Updated Sydney System. HIF-1[alpha] protein expression increased significantly from SE to Barrett's metaplasia (BM) (P &lt; 0.0001). From metaplasia through low- and high-grade dysplasia to cancer, no further increase could be detected. Active and chronic inflammation were also significantly different between SE and BM (P &lt; 0.0001) but not during furth...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277444</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277444</guid>        </item>
        <item>
            <title>Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2277443&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00958.x</link>
            <description>In conclusion, ILHDR BT of advanced squamous esophageal cancer consisting of two out-patient procedures is very successful in achieving the primary objectives of the patients to reduce dysphagia and improve QOL. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277443</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277443</guid>        </item>
        <item>
            <title>Thirty-four cases of esophageal perforation: the experience of a district general hospital in the UK</title>
            <link>http://www.medworm.com/index.php?rid=2277442&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00959.x</link>
            <description>Esophageal perforation is uncommon and traditionally has a high rate of morbidity and mortality. Our aim was to perform a 13-year retrospective review of the cases managed in our district general hospital. Thirty-four cases of esophageal perforation diagnosed between 1995 and 2008 were retrospectively analyzed. There were 20 males and 14 females with a median age of 64 (range 23[ndash]86) years. The etiology of the perforations were Boerhaave's syndrome (n= 19), therapeutic endoscopy (n= 9), diagnostic endoscopy (n= 2), gastric lavage injury (n= 1), foreign body (n= 1), blunt chest trauma (n= 1), and spontaneous tumor perforation (n= 1). Only 11 cases (32%) had evidence of surgical emphysema upon examination. In 50% of cases, another clinical diagnosis was initially suspected. Twenty-four ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277442</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277442</guid>        </item>
        <item>
            <title>p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2277441&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00960.x</link>
            <description>p53 Arg72Pro, MDM2 T309G, and CCND1 G870A are functional single-nucleotide polymorphisms (SNPs) in key genes that regulate apoptosis and cell cycle. Variant genotypes of these SNPs have been associated with increased risk and earlier age of onset in some cancers. We investigated the association of these SNPs with susceptibility to esophageal adenocarcinoma in a large, North American case-control study. Three hundred and twelve cases and 454 cancer-free controls recruited in Boston, USA were genotyped for each of the three SNPs, and demographic and clinical data were collected. Genotype frequencies for each of the three SNPs did not deviate from the Hardy[ndash]Weinberg equilibrium, and did not differ between cases and controls. Odds ratios (OR), adjusted for clinical risk factors, for the ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277441</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277441</guid>        </item>
        <item>
            <title>Gastric secretory and hormonal patterns in end-stage chagasic achalasia</title>
            <link>http://www.medworm.com/index.php?rid=2277440&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00961.x</link>
            <description>Achalasia surgical treatment alters the esophagogastric junction anatomy (cardiomyotomy plus fundoplication or esophagectomy and gastric pull-up), thus favoring a certain degree of gastroesophageal reflux. Gastric secretory and hormonal functioning is not completely known in chagasic patients. The aim of this study was to evaluate the gastric secretory and hormonal response in patients with end-stage chagasic achalasia compared with normal subjects. Gastric secretion and hormonal response were assessed by estimation of gastric acid secretion (GAS) in basal condition and after pentagastrin stimulation, basal serum gastrin, and serum pepsinogen (SP) in basal condition and after betazole hydrochloride (Histalog®; Eli Lilly and Company, Indianapolis, IN, USA) stimulation in 27 patients with c...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277440</comments>
            <pubDate>Tue, 17 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2277440</guid>        </item>
        <item>
            <title>Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=2248395&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00954.x</link>
            <description>In conclusion, the most frequent complication with ESD was esophageal stenosis, for which the sizes of the tumor and mucosal defect were significant predictive factors. Although ESD enables large en bloc resection of esophageal cancer, practically, in cases with a lesion more than half of the circumference, great care must be taken because of the high risk of post-ESD stenosis. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248395</comments>
            <pubDate>Sun, 08 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248395</guid>        </item>
        <item>
            <title>Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis</title>
            <link>http://www.medworm.com/index.php?rid=2248401&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00948.x</link>
            <description>Greater than 50% of patients with esophageal carcinoma are found to be incurable at the time of diagnosis, leaving only palliative options. Self-expanding metal stents (SEMs) are effective for relieving symptoms and complications associated with esophageal carcinoma and improving quality of life. We undertook a retrospective analysis to evaluate the experience of palliative esophageal stenting for symptomatic malignant dysphagia in our institution over a period of 7 years. Between January 1999 and January 2006, 126 patients who received SEMs for malignant dysphagia were identified using an upper gastrointestinal specialist nurse clinician database. Data were obtained from patient case notes, endoscopy, histopathology, radiology, and external agency databases. Of the 126 identified, 36 pati...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248401</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248401</guid>        </item>
        <item>
            <title>Prevalence of esophageal dysmotility in a cohort of patients with esophageal biopsies consistent with eosinophilic esophagitis</title>
            <link>http://www.medworm.com/index.php?rid=2248400&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00949.x</link>
            <description>The objective of this study was to evaluate the prevalence of esophageal dysmotility in a cohort of patients with biopsies consistent with EoE at a military treatment facility. This is a prospective evaluation of consecutively identified patients at our institution diagnosed with EoE from March 1, 2005 to June 1, 2007. Thirty-two patients with biopsies consistent with EoE completed a symptom survey and 30 underwent esophageal manometry. The majority of EoE patients (23/30, 77%) had a normal end-expiratory lower esophageal sphincter (LES) pressure (normal range 10[ndash]35), whereas six patients had a low-normal LES pressure (6[ndash]9 mm Hg) and one patient had a decreased LES pressure (180 mm Hg (188 mm Hg, 209 mm Hg). No patient was diagnosed with nutcracker esophagus or diffuse esophage...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248400</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248400</guid>        </item>
        <item>
            <title>Comparative study of different treatments for malignant tracheoesophageal/bronchoesophageal fistulae</title>
            <link>http://www.medworm.com/index.php?rid=2248399&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00950.x</link>
            <description>The aim of this study is to compare the survival time and quality of life (QOL) of patients who have received different treatment for tracheoesophageal/bronchoesophageal fistula. Between January 2003 and December 2007, 35 patients with malignant tracheoesophageal/bronchoesophageal fistula were recorded as the control group, gastrostomy group, and stenting group, respectively, according to the treatments they chose. Two weeks after the treatment, European Organization for Research and Treatment of Cancer Quality of Life Core 30 Questionnaire (QLQ-C30), Quality of Life Questionnaire-esophageal module (QLQ-OES18), and a respiratory symptom-related QOL index are employed to assess QOL of these patients. There is no significant difference in survival time and constituent ratio of death reason a...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248399</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248399</guid>        </item>
        <item>
            <title>Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis</title>
            <link>http://www.medworm.com/index.php?rid=2248398&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00951.x</link>
            <description>Neoadjuvant chemotherapy may improve the outcome of esophageal cancer after esophagectomy, but is accompanied by considerable toxicity by collateral destruction of normal cells. Such side effects may be avoided by developing therapies that specifically target molecular characteristics of tumors. The aim of the present study was to determine the proportion of esophageal squamous cell carcinoma (ESCC) patients that could possibly benefit from (a combination of) currently available targeted therapies, by assessing the frequency of immunohistochemical expression of their target molecular markers in ESCC tissues. Sections from a validated tissue microarray comprising 108 ESCCs were immunohistochemically stained for Bcl-2, c-KIT, cyclo-oxygenase-2 (COX-2), cyclin D1, estrogen receptor (ER), epid...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248398</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248398</guid>        </item>
        <item>
            <title>Endocytoscopic observation for esophageal squamous cell carcinoma: can biopsy histology be omitted?</title>
            <link>http://www.medworm.com/index.php?rid=2248397&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00952.x</link>
            <description>We examined whether endocytoscopic observation of esophageal squamous cell carcinoma can replace the histologic examination of biopsy specimens. In a basic investigation, we examined 57 iodine-unstained areas in the resected specimens of the esophagus from 28 individuals. The endocytoscopic findings were graded from 0 to 3 in tandem with observations of the iodine staining. For endocytoscopic observation, we sprayed 1% methylene blue or toluidine blue as a vital dye on the surface of the esophageal mucosa, allowing 15[ndash]20 s for sufficient staining. One endoscopist observed the target lesions and decided their endocytoscopic type classification. Histological diagnoses were made by two pathologists who were unaware of the endoscopic findings. We then compared the endocytoscopic diagnosi...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248397</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248397</guid>        </item>
        <item>
            <title>P53 and Ki-67 overexpression in gastroesophageal reflux disease &amp;#x2013; Barrett's esophagus and adenocarcinoma sequence</title>
            <link>http://www.medworm.com/index.php?rid=2248396&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00953.x</link>
            <description>This study aims to determine p53 protein and Ki-67 expression in esophageal mucosa of patients with GERD and study the correlation between these markers and the progression from normal squamous epithelium to esophagitis, columnar epithelium with or without intestinal metaplasia and ACE. We analyzed p53 protein and Ki-67 expression in biopsies of 200 patients with GERD and 35 patients with ACE. Those biopsies were classified into five groups: (i) G1 normal squamous epithelium (58); (ii) G2 esophagitis (80); (iii) G3 columnar epitheliums without intestinal metaplasia (30); (iv) G4, columnar epitheliums with intestinal metaplasia (32); and (v) G5 ACEs (35). p53 protein overexpression was found in 7% (4) of G1, 37.5% (30) of G2, 30% (9) of G3, 62.5% (20) of G4, and 71.4% (25) of G5 (p &lt; 0.001)...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2248396</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2248396</guid>        </item>
        <item>
            <title>Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=2186174&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00947.x</link>
            <description>Although several studies have examined the association between phase I/II enzyme polymorphisms and esophageal adenocarcinoma (EAC) and/or Barrett's esophagus (BE), their overall findings remain unclear. We performed a systematic review and meta-analysis to determine whether phase I/II polymorphisms are independent risk factors for either BE or EAC. We employed keyword searches in multiple databases to identify studies published before October 1, 2007. Single-nucleotide polymorphisms (SNPs) examined in [ge]3 studies were meta-analyzed to obtain a pooled estimate of effect. Meta-analysis suggested the minor allele for GSTP1 Val105 conveys modest excess risk (odds ratio [OR]BE= 1.50, 95% confidence interval [CI] 1.16[ndash]1.95; OREAC= 1.20, 95% CI 0.94[ndash]1.54). No excess risk was observe...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186174</comments>
            <pubDate>Sun, 15 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186174</guid>        </item>
        <item>
            <title>Association of erosive esophagitis with Helicobacter pylori eradication: a role of salivary bicarbonate and glycoprotein secretion</title>
            <link>http://www.medworm.com/index.php?rid=2186183&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00938.x</link>
            <description>In some populations, Helicobacter pylori eradication is associated with development of erosive esophagitis. The aim of this study was to evaluate the contribution of salivary bicarbonate and glycoprotein secretion to the pathogenesis of erosive esophagitis developing after H. pylori eradication. Gastroscopy and saliva collection were performed at recruitment and 12 months after completion of eradication therapy. Eighty-eight patients with duodenal ulcer were recruited to the study. Erosive esophagitis was found in 13 patients (grade A, 8 patients; grade B, 4 patients; grade C, 1 patient). Among the 74 subjects who completed the study, erosive esophagitis was detected in 21 patients (grade A, 15 patients; grade B, 6 patients); they all were successfully eradicated. Bicarbonate and glycoprot...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186183</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186183</guid>        </item>
        <item>
            <title>The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2186182&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00939.x</link>
            <description>Studies have shown that weight loss is associated with adverse outcomes in all treatment modalities for esophagogastric carcinoma. Because of the increased prevalence of obesity and the effectiveness of perioperative nutrition, a number of patients are now obese or have normal body mass index (BMI) at the time of treatment. We investigated the relationship between weight loss, BMI, and outcome of surgery for patients with esophagogastric carcinoma. Data were collected over a 38-month period for all patients diagnosed with operable esophagogastric cancer at two UK centers. All patients underwent resection by a single Consultant Upper Gastrointestinal Surgeon and the use of perioperative jejunal feeding was universal. Ninety-three patients (57 male) underwent esophagogastric resection; 48 ha...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186182</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186182</guid>        </item>
        <item>
            <title>Symptoms with acid and nonacid reflux may be produced by different mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=2186181&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00940.x</link>
            <description>Twenty-four-hour multichannel intraluminal impedance and pH (MII-pH) esophageal monitoring detects both acid and nonacid gastroesophageal reflux episodes. The MII-pH catheter contains six impedance segments placed 3, 5, 7, 9, 15, and 17 cm above the lower esophageal sphincter (LES). A pH electrode at 5 cm above the LES identifies the type of reflux, i.e. acid or nonacid. Patients with acid and nonacid reflux exhibit typical and atypical symptoms often within 5 min following a reflux episode. The aim of this study is to compare the timing of symptoms after reflux episodes in patients with acid and nonacid reflux. Methods include a review of 70 MII-pH tracings (42 females, mean age 40, range 18[ndash]85 years) either on (50 points) or off (20 points) acid suppression therapy. Typical (heartb...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186181</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186181</guid>        </item>
        <item>
            <title>Prognostic value of maximum standardized uptake values from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone</title>
            <link>http://www.medworm.com/index.php?rid=2186180&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00941.x</link>
            <description>Preoperative staging for esophageal adenocarcinoma is suboptimal for predicting outcomes when compared with pathological data. The aim of this study was to assess if the quantitative values obtained by preoperative 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) are independent prognostic indicators for survival in patients with resectable adenocarcinoma of the esophagus undergoing surgical treatment without neoadjuvant therapy. Patients were identified from a prospective database, survival analyses were undertaken using log rank and Cox method. The median follow-up was 44 months (range 18[ndash]61 months). Between November 2002 and November 2005, 45 consecutive patients underwent FDG-PET followed by surgery. The median age was 72 years (range 38[ndash]82 years). On univariat...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186180</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186180</guid>        </item>
        <item>
            <title>Magnifying endoscopy with narrow band imaging for predicting the invasion depth of superficial esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2186179&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00942.x</link>
            <description>The invasion depth of superficial esophageal squamous cell carcinoma is important in determining therapeutic strategy. The aim of this study was to prospectively investigate the clinical utility of magnifying endoscopy with narrow band imaging compared with that of non-magnifying high-resolution endoscopy or high-frequency endoscopic ultrasonography in predicting the depth of superficial esophageal squamous cell carcinoma. The techniques were carried out in 72 patients with 101 superficial esophageal squamous cell carcinomas, which were then resected by either endoscopic mucosal resection or esophagectomy. The histological invasion depth was divided into two: mucosal or submucosal carcinoma. We investigated the relationship between endoscopic staging and histology of tumor depth. Non-magni...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186179</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186179</guid>        </item>
        <item>
            <title>Long-term symptomatic outcomes after Collis gastroplasty with fundoplication</title>
            <link>http://www.medworm.com/index.php?rid=2186178&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00943.x</link>
            <description>Collis gastroplasty with fundoplication is an accepted treatment for gastroesophageal reflux disease (GERD) complicated by short esophagus. The procedure can be done either via left thoracotomy or using minimally invasive laparoscopic techniques. Few centers have reported long-term follow-up for patients undergoing a Collis gastroplasty using both the open and minimal access techniques. Retrospective review of prospectively collected data at Creighton University was done to identify patients who underwent Collis gastroplasty with fundoplication for GERD. After approval from the institutional review board, the patients were contacted and administered a questionnaire regarding symptoms and satisfaction. Data were entered in a dataset and analyzed from the patient's perspective. Eighty-five p...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186178</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186178</guid>        </item>
        <item>
            <title>Characterization of mast cell subtypes, distribution, and antigen-induced activation in the guinea pig esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2186177&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00944.x</link>
            <description>In conclusion, MCs in the guinea pig esophagus have unique features in immunophenotypes, distribution, and degranulation response to OVA challenge with the release of significant amounts of proteases and histamine into the tissue. These characteristics may indicate that OVA in vitro challenge in OVA-sensitized guinea pig esophagus could be a good model to study the role of esophageal MCs in allergic and inflammation conditions. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186177</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186177</guid>        </item>
        <item>
            <title>Gastric fundus tension before and after division of the short gastric vessels in a cadaveric model of fundoplication</title>
            <link>http://www.medworm.com/index.php?rid=2186176&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00945.x</link>
            <description>This study aims to evaluate in a cadaveric model of Nissen fundoplication: (i) the correlation of GF tension with anatomic parameters; and (ii) the effect of SGV division on GF tension. In total, 23 fresh cadavers (18 men, mean age 62 years) were studied. The abdominal esophagus was dissected, and the GF transposed to a limit of 3 cm to the right border of the esophagus. A dynamometer was attached to the GF and the tension recorded. Cadavers were grouped according to the presence or absence of tension. SGV were divided and GF tension measured again. The presence or absence of initial GF tension was correlated to: (i) number of SGV; (ii) length of the GF; (iii) distance between His angle and the first SGV; and (iv) size of the spleen. The mean GF pressure was 0.5 N ± 1.0 (0[ndash]2.5) befo...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186176</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186176</guid>        </item>
        <item>
            <title>Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification</title>
            <link>http://www.medworm.com/index.php?rid=2186175&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2009.00946.x</link>
            <description>The incidence of adenocarcinoma of the esophagogastric junction (AEG) has been increasing in Western countries. It is unclear, however, whether similar changes are occurring in Asia. We therefore investigated the incidence of AEG in Korea, and assessed the clinical characteristics of three types of AEG based on Siewert's classification. We retrospectively reviewed the medical records of 16 811 patients diagnosed with esophageal squamous cell carcinoma (ESC, n= 1450) or gastric noncardiac adenocarcinoma (GNCA, n= 14 751) between 1992 and 2006. The patients were divided into three 5-year cohorts (cohort A [1992[ndash]1996], n= 2734, cohort B [1997[ndash]2001], n= 5727, and cohort C [2002[ndash]2006], n= 8350), and the ratios of AEG (n= 610) to non-AEG (ESC and GNCA) in each cohort were compa...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2186175</comments>
            <pubDate>Fri, 13 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2186175</guid>        </item>
        <item>
            <title>Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery</title>
            <link>http://www.medworm.com/index.php?rid=2127704&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00936.x</link>
            <description>The aim of this study was to retrospectively analyze and assess the outcomes and prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery. One hundred twenty-six patients with node-positive thoracic esophageal squamous cell carcinoma who had undergone adjuvant therapy (postoperative radiotherapy alone or postoperative sequential chemoradiotherapy without receiving postoperative concurrent chemoradiotherapy) after radical surgery, were retrospectively reviewed from January 1996 to December 2003. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazard models, and survival curves were estimated using the Kaplan-Meier method. The 1-, 3- and 5-year overall survival rates of all 126 ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127704</comments>
            <pubDate>Sat, 24 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127704</guid>        </item>
        <item>
            <title>Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction</title>
            <link>http://www.medworm.com/index.php?rid=2127717&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00923.x</link>
            <description>Precise classification of cancers of the esophagogastric junction according to Siewert may be difficult for the presence of Barrett's esophagus or hiatal hernia, which subsequently leads to a difficult choice of the surgical procedure of esophagectomy or gastrectomy. Ninety-six patients with such cancers were operated on in our department in 7 years. Twenty-nine patients (30.2%), classified as type I (group 1), underwent a transthoracic esophagectomy with gastric pull up. Sixty-seven patients (69.8%) classified as type II or III (group 2) underwent an extended gastrectomy. We compared the patients of both groups retrospectively for disease-free survival and postoperative complications. The general performance status of most patients was comparable in both groups and was assigned to the Ame...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127717</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127717</guid>        </item>
        <item>
            <title>The characteristics of Barrett's esophagus: an analysis of 4120 cases in China</title>
            <link>http://www.medworm.com/index.php?rid=2127716&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00924.x</link>
            <description>Our objective was to investigate the endoscopic and clinico-pathological characteristics in patients with Barrett's esophagus (BE) in China. Using the terms 'Barrett's esophagus' and 'Barrett's esophagus, China' as key words, literatures published in Chinese and English journals were searched in Chinese data banks, as well as PubMed and ISI Web of Science from 1989 to 2007. An analysis was carried out with the standard inclusion and exclusion criteria. A total of 4120 cases were included in this study. BE was found in 2.44% of patients undergoing endoscopy for various symptoms of upper gastrointestinal tract diseases; the male : female ratio was 2.09 : 1, the average age of detection of BE was 53.15 years old, and 51% of patients with BE had typical symptoms for gastroesophageal reflux dis...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127716</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127716</guid>        </item>
        <item>
            <title>Assessment of novel endoscopic techniques for visualizing superficial esophageal squamous cell carcinoma: autofluorescence and narrow-band imaging</title>
            <link>http://www.medworm.com/index.php?rid=2127715&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00925.x</link>
            <description>This study aimed to assess the visualizing power of white-light imaging (WLI), NBI, and AFI, compared with LCE. Sixteen patients with 16 SESCCs underwent LCE and endoscopy with NBI and AFI before endoscopic or surgical treatment. Twenty sets of endoscopic SESCC images were prepared, each of which contained still images from WLI, NBI, AFI, and LCE. The image sets were shown to 25 endoscopists, who then each completed a questionnaire about the ease-of-detection of the SESCCs, scoring WLI, NBI, and AFI images with reference to a perfect score for LCE; mean scores were compared. Overall, significantly higher scores were given for NBI than for WLI and AFI, with no significant difference between WLI and AFI. Stratification by endoscopist characteristics indicated that younger or less experienced...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127715</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127715</guid>        </item>
        <item>
            <title>Surgical repair of refractory strictures of esophagogastric anastomoses caused by leakage following esophagectomy</title>
            <link>http://www.medworm.com/index.php?rid=2127714&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00926.x</link>
            <description>Refractory strictures of esophagogastric anastomosis caused by leakage following an esophagectomy are a severe complication, for which either repeated balloon dilations or bougies are not necessarily effective. In such a case, surgical repair is quite difficult because the esophageal substitute such as the stomach or colon is usually located in the mediastinum and severely adhesive to the neighboring organs. Furthermore, in case the resected stricture is too long for direct re-anastomosis to be performed, a free jejunal graft or a new esophageal substitute should be prepared. This paper proposes a procedure for the re-reconstruction of refractory stricture in the case of a retrosternal reconstruction with a gastric conduit, which frequently employs pull-up route. The anterior plate of the ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127714</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127714</guid>        </item>
        <item>
            <title>Management of delayed intrathoracic esophageal perforation with modified intraluminal esophageal stent</title>
            <link>http://www.medworm.com/index.php?rid=2127713&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00927.x</link>
            <description>In this article, we reviewed our experience of treatment of the delayed intrathoracic nonmalignant esophageal perforation employing modified intraluminal esophageal stent. Between February 1990 and August 2006, eight patients were included in this study. Five patients experienced sepsis. The interval time between perforation and stent placement ranged from 36 h to 27 days (average, 8.6 days). Esophageal stenting and throracotomy for foreign body removal were performed in four patients. The remaining four patients underwent stent placement and thoracostomy. Nutrition was initiated through gastrostomy after 7 to 10 days after the stenting. The stent was removed after the patients resumed oral intake of food and the esophagogram showed that perforation was closed. There was no death in this g...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127713</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127713</guid>        </item>
        <item>
            <title>Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2127712&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00928.x</link>
            <description>Matrix metalloproteinases (MMPs) are known to play important roles in extracellular matrix remodeling during the process of tumor invasion and metastasis. However, little is known about their role in esophageal squamous cell carcinoma (ESCC). Expression of MMP-2 and MMP-9 in ESCC was detected in our research. Tissue microarray chip was prepared, consisting of 58 cases of ESCC and corresponding esophageal epithelium tissues. MMP-2 and MMP-9 were examined by immunohistochemistry. Overexpression of MMP-2 and MMP-9 was found in ESCC (42.1 and 60.3%, respectively), compared with paired distal normal esophageal tissues (22.9 and 8.9%, respectively). Expression of MMP-2 in ESCC was significantly associated with the tumor invasion depth, tumor-node-metastasis stages, and lymph node metastasis. MMP...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127712</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127712</guid>        </item>
        <item>
            <title>International survey on esophageal cancer: part I surgical techniques</title>
            <link>http://www.medworm.com/index.php?rid=2127711&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00929.x</link>
            <description>In conclusion, currently the most commonly applied surgical procedure is the open right-sided transthoracic approach with a two-field lymphadenectomy, using a gastric tube anastomosed at the left side of the neck by means of a handsewn, end-to-side technique. The results of this survey provide baseline data for future research and for the development of international guidelines. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127711</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127711</guid>        </item>
        <item>
            <title>International survey on esophageal cancer: part II staging and neoadjuvant therapy</title>
            <link>http://www.medworm.com/index.php?rid=2127710&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00930.x</link>
            <description>In conclusion, currently the most commonly applied diagnostic modalities for staging and restaging esophageal cancer are CT scanning of the chest and abdomen, gastroscopy, barium esophagography and EUS. Neoadjuvant therapy is routinely applied by one third of the responders. Intercontinental differences have been detected in the diagnostic modalities applied in esophageal cancer staging and in the administration of neoadjuvant therapy. The results of this survey provide baseline data for future research and for the development of international guidelines. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127710</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127710</guid>        </item>
        <item>
            <title>Self-expanding plastic stents for inoperable malignant strictures of the cervical esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2127709&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00931.x</link>
            <description>Dysphagia and respiratory complications are the major problems in patients suffering from malignant strictures of the cervical esophagus. In inoperable cases, interventional palliation is the cornerstone of treatment. The aim of this study was to evaluate the use of self-expanding plastic stents (SEPS) in this group of patients. In a retrospective study, 23 patients suffering from various malignant obstructive diseases of the cervical esophagus, including squamous cell carcinoma (n= 10), laryngeal cancer (n= 7), lung cancer with esophageal invasion (n= 5), and metastatic breast cancer (n= 1), underwent SEPS placement, under endoscopic and fluoroscopic guidance. Tracheoesophageal fistula was documented in five patients. Technical success rate, improvement of dysphagia grade, and stent-relat...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127709</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127709</guid>        </item>
        <item>
            <title>A study comparing tolerability, satisfaction and acceptance of three different techniques for esophageal endoscopy: sedated conventional, unsedated peroral ultra thin, and esophageal capsule</title>
            <link>http://www.medworm.com/index.php?rid=2127708&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00932.x</link>
            <description>Three methods of esophagoscopy are available until now: sedated conventional endoscopy, unsedated ultrathin endoscopy, and esophageal capsule endoscopy. The three methods carry comparable diagnostic accuracy and different complication rates. Although all of them have been found well accepted from patients, no comparative study comprising the three techniques has been published. The aim of this study was to compare the three methods of esophagoscopy regarding tolerability, satisfaction, and acceptance. Twenty patients with large esophageal varices and 10 with gastroesophageal reflux disease were prospectively included. All patients underwent consecutively sedated conventional endoscopy, unsedated ultrathin endoscopy, and esophageal capsule endoscopy. After each procedure, patients completed...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127708</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127708</guid>        </item>
        <item>
            <title>Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients</title>
            <link>http://www.medworm.com/index.php?rid=2127707&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00933.x</link>
            <description>In conclusion, the eradication of H. pylori increases the prevalence of reflux esophagitis, and hiatus hernia was a significant risk factor for the development of reflux esophagitis. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127707</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127707</guid>        </item>
        <item>
            <title>Endoscopy of the esophagus in gastroesophageal reflux disease: are we losing sight of symptoms? Another perspective</title>
            <link>http://www.medworm.com/index.php?rid=2127706&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00934.x</link>
            <description>Gastroesophageal reflux disease (GERD) is an extremely common chronic disorder associated with impaired quality of life and huge economic burden. Recently, an International Consensus Group developed a global definition of GERD (The Montreal Definition): a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. The traditional endoscopy-based classification of GERD patients into one of three groups [ndash] non-erosive reflux disease, erosive esophagitis, and Barrett's esophagus [ndash] is fraught with several limitations. Due to the lack of a gold standard, GERD is a symptom-based diagnosis, and hence symptom evaluation will remain the primary means by which treatment decisions are made for patients with suspected GERD. We propose that p...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127706</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127706</guid>        </item>
        <item>
            <title>Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2127705&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00935.x</link>
            <description>We retrospectively investigated the efficacy of a chemoradiotherapy regimen using daily low-dose cisplatin and continuous 5-fluorouracil infusion in 71 registered patients with unresectable esophageal cancer. The overall response rate (complete response plus partial response) was 59%. The major toxicities observed were leukopenia and anorexia. The 1- and 3-year overall survival rates were 54.6% and 18.4%, respectively. A low preoperative C-reactive protein level was found to be associated with a good response. The pretreatment performance status and response results were both shown to be prognostic factors for overall survival. These findings confirmed that the chemoradiotherapy regimen had curative potential for unresectable esophageal cancer. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127705</comments>
            <pubDate>Fri, 23 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2127705</guid>        </item>
        <item>
            <title>Economic analysis of esophageal stenting for management of malignant dysphagia</title>
            <link>http://www.medworm.com/index.php?rid=2099974&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00916.x</link>
            <description>Over half of patients diagnosed with esophageal cancer are unsuitable for curative resection. A significant proportion of these patients will subsequently require palliative stenting to alleviate dysphagia. There is growing consensus in the literature that the deployment of a Self-Expanding Metal Stent is the optimum stenting strategy; however, it remains unclear whether covered or uncovered metal stents are more cost-effective. In order to determine which type of prosthesis is more cost-effective, we compared the different stenting strategies in terms of 1-year stent-related mortality, health-related quality of life, and cost. A decision analytical model was constructed to compare the 1-year stent-related mortality, health-related quality of life, and cost between covered and uncovered st...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099974</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099974</guid>        </item>
        <item>
            <title>Minimally invasive surgical enucleation for esophageal leiomyoma: report of seven cases</title>
            <link>http://www.medworm.com/index.php?rid=2099973&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00917.x</link>
            <description>We present our experience with enucleation of esophageal leiomyomas using a minimally invasive approach. Between March 1998 and June 2008, seven patients with esophageal leiomyoma underwent right thoracosopic enucleation (n = 4) or laparoscopic transhiatal enucleation (n = 3). A Dor (n = 2) or Toupet fundoplication (n = 1) were added for laparoscopic procedure. The mean tumor size was 3.9 cm (range, 1.5[ndash]5.5 cm). Tumor locations were upper (n = 2), middle (n = 1), and lower (n = 4) thirds of the esophagus. No major morbidities including postoperative leakage or mortalities occurred. At a mean follow-up period of 60.1 months (range, 14[ndash]260 months), no evidence of recurrences were observed. Thoracoscopic and laparoscopic transhiatal enucleation for esophageal leiomyomas is a safe ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099973</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099973</guid>        </item>
        <item>
            <title>Current management of esophageal perforation: 20 years experience</title>
            <link>http://www.medworm.com/index.php?rid=2099972&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00918.x</link>
            <description>Esophageal perforations are surgical emergencies associated with high morbidity and mortality rates. No single strategy has been sufficient to deal with the majority of situations. We aim to postulate a therapeutic algorithm for this complication based on 20 years of experience and also on data from published literature. We performed a retrospective clinical review of 44 patients treated for esophageal perforation at our hospital between January 1989 and May 2008. We reviewed the characteristics of these patients, including age, gender, accompanying diseases, etiology of perforation, diagnosis, location, time interval between perforation and diagnosis, treatment of the perforation, morbidity, hospital mortality, and duration of hospitalization. Perforation occurred in the cervical esophagu...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099972</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099972</guid>        </item>
        <item>
            <title>Outcomes of surgical treatment of intrathoracic stomach</title>
            <link>http://www.medworm.com/index.php?rid=2099971&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00919.x</link>
            <description>The purpose of this study is to assess the long-term outcomes after surgical repair of intrathoracic stomach. Prospectively collected data was retrospectively reviewed. Patients underwent a phone questionnaire 1 year postoperatively to assess gastroesophageal reflux disease-related symptoms and surgical satisfaction. In addition, objective evaluation for integrity of hiatal hernia repair was undertaken either by esophagram or endoscopy. Any recurrence was considered a failure. Forty-one patients underwent surgical repair of a large paraesophageal hernia with intrathoracic stomach during the study period. Thirty-four patients underwent a laparoscopic repair, and seven patients underwent a transthoracic repair. An antireflux procedure was performed on 28 patients, and 13 patients had only he...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099971</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099971</guid>        </item>
        <item>
            <title>Angleplasty in gastric tube reconstruction after esophagectomy</title>
            <link>http://www.medworm.com/index.php?rid=2099970&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00920.x</link>
            <description>Anastomotic leakage after radical esophagectomy is mostly caused by the hypoxia and high tension at the esophagogastric anastomotic site. Here, we introduce a new surgical technique, 'Angleplasty,' to enable the tensionless anastomosis at a highly oxygenic site of gastric conduit. In short, the seromuscular layer is cut for a perpendicular direction against a lesser curvature at a gastric angle and the gastric wall is carefully divided between the muscular and submucosal layers for longitudinal direction for 4[ndash]5 cm in length. Then, the wound is closed with seromuscular sutures for longitudinal direction. With this maneuver, the lesser curvature of the gastric roll is significantly elongated and the anastomosis site of the gastric conduit can be moved more distal on the greater curvat...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099970</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099970</guid>        </item>
        <item>
            <title>Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2099969&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00921.x</link>
            <description>Cortactin, fascin, and survivin have been documented in several human cancers and play important roles in tumor progression. We collected 57 surgical specimens, including esophageal squamous cell carcinomas (SqCC; 7 well-differentiated, 15 moderately differentiated, and 24 poorly differentiated), 3 dysplasias, and 8 normal esophageal tissues. Tissue microarrays were constructed and the immunostaining scores for cortactin, fascin, and survivin were assessed. In 46 SqCC specimens, we examined the relationship between the expression of three biomarkers and tumor differentiation or clinical parameters. Higher immunostaining scores for cortactin, fascin, and survivin correlated positively with tumor differentiation of esophageal SqCC. Univariate survival analysis showed significantly worse prog...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099969</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099969</guid>        </item>
        <item>
            <title>An increased proportion of inflammatory cells express tumor necrosis factor alpha in idiopathic achalasia of the esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2099968&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00922.x</link>
            <description>In conclusion, a higher proportion of infiltrating inflammatory cells expressed tumor necrosis factor alpha in achalasia. Furthermore, this proportion appears to be highest early in the disease process. Further studies are required to more clearly delineate the role of tumor necrosis factor alpha in the pathogenesis of this idiopathic disease. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2099968</comments>
            <pubDate>Tue, 13 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2099968</guid>        </item>
        <item>
            <title>Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship</title>
            <link>http://www.medworm.com/index.php?rid=2086158&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00911.x</link>
            <description>A possible association between gastroesophageal reflux disease (GERD) and Helicobacter pylori (H. pylori) infection has been the subject of study and debate in recent years. This review discusses the pathophysiological and immunological mechanisms implicated in this relationship. Although gastric secretion in the majority of H. pylori-infected individuals is unaltered, this review considers how the bacteria may interfere with gastric acid production and what role it may play in GERD. We also identify the epidemiological evidence that confirms that GERD develops after the infection has been eradicated. Lastly, we clarify how the host's immune response and bacterial virulence factors interfere with this relationship, explaining the highly conflicting results in the literature. (Source: Disea...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2086158</comments>
            <pubDate>Tue, 06 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2086158</guid>        </item>
        <item>
            <title>Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life</title>
            <link>http://www.medworm.com/index.php?rid=2082990&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00906.x</link>
            <description>The aim of palliation in patients with inoperable esophageal cancer is to relieve dysphagia with minimal morbidity and mortality, and thus improve quality of life (QOL). The use of a self-expanding metal stent (SEMS) is a well-established modality for palliation of dysphagia in such patients. We assessed the QOL after palliative stenting in patients with inoperable esophageal cancer. Thirty-three patients with dysphagia due to inoperable esophageal cancer underwent SEMS insertion between October 2004 and December 2006. All patients had grade III/IV dysphagia and locally advanced unresectable cancer (n = 13), distant metastasis (n = 14), or comorbid conditions/poor general health status precluding a major surgical procedure (n = 6). Patients with grade I/II dysphagia and those with carcinom...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082990</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082990</guid>        </item>
        <item>
            <title>Ion transport and barrier function in a telomerase-immortalized human nondysplastic, Barrett's cell line (BAR-T)</title>
            <link>http://www.medworm.com/index.php?rid=2082989&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00907.x</link>
            <description>Barrett's specialized columnar epithelium (SCE) replaces reflux-damaged squamous epithelium. The benefits of SCE lie in its superior protection of the esophagus against further reflux damage. It was shown that this protection is dependent on ion transport and barrier function of SCE. The risks of SCE lie in its higher predisposition to malignant transformation. An understanding of underlying mechanisms of both processes would benefit considerably from greater knowledge of the structure and function of native SCE [ndash] the latter recently advanced by the availability of a telomerase-immortalized, nonneoplastic, human Barrett's cell line (BAR-T). Some of BAR-T characteristics for growth and differentiation have been described recently, but not its capacity to serve as a model for ion trans...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082989</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082989</guid>        </item>
        <item>
            <title>Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance</title>
            <link>http://www.medworm.com/index.php?rid=2082988&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00908.x</link>
            <description>The incidence of Barrett's esophagus (BE) and esophageal adenocarcinoma has increased in Western countries in recent decades. The aim of this study is to describe the changes in incidence and prevalence of BE diagnosis, dysplasia, and adenocarcinoma development in BE patients in a South-European Mediterranean area. Retrospective population-based analyses of endoscopy and pathology reports from 1976 to 2001 was performed. Data from patients with diagnosis of BE and/or esophageal carcinoma were collected. The study period was divided in four quartiles for statistical calculations; parametric and nonparametric tests were used. A 6.9-fold increase was found in the diagnosis of long-segment BE from the first to the fourth quartile, and a 9.3-fold increase in short-segment BE from 1995 to 2000, ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082988</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082988</guid>        </item>
        <item>
            <title>Endoscopic evaluation of esophago&amp;#x2013;gastro&amp;#x2013;jejunostomy in rat model of Barrett's esophagus</title>
            <link>http://www.medworm.com/index.php?rid=2082987&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00909.x</link>
            <description>Endoscopy can be used to monitor the onset of metaplastic transformation and to observe the progression of neoplasia in small animal models of Barrett's esophagus. By avoiding animal sacrifice, the natural history of this disease can be studied in a longitudinal fashion. We aim to characterize the endoscopic features of esophageal mucosa at various stages of the metaplasia-dysplasia-carcinoma sequence in a rat reflux model of Barrett's for comparison with histology. Acid and bile reflux was produced by introducing a side-to-side esophago[ndash]gastro[ndash]jejunostomy in Sprague[ndash]Dawley rats. Endoscopic examination of the distal esophagus was performed in 24 surgically altered and 4 control rats, between weeks 24 and 36 after the operation in 4-week intervals, and all rats were biopsi...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082987</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082987</guid>        </item>
        <item>
            <title>Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2082986&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00912.x</link>
            <description>This study was designed to investigate the correlation of XRCC1 Arg194Trp Arg280His and Arg399Gln SNPs with the risk of gastric cardiac adenocarcinoma (GCA). Genotypes were analyzed by polymerase chain reaction-restriction fragment length polymorphism assay in 455 patients with GCA and 650 age- and sex-matched controls. We did not find any significant difference in allele and genotype distributions of Arg194Trp Arg399Gln between the groups (P &gt; 0.05). However, a significant increase in GCA risk was seen among smokers if they carried at least one XRCC1 280His (Arg280His + His280His) genotype (odds ratio = 1.59, 95% confidence interval = 1.01[ndash]2.51) compared with smokers not carrying these genotype. Our results indicated that XRCC1 Arg194Trp and Arg399Gln SNPs might not be associated wi...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082986</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082986</guid>        </item>
        <item>
            <title>The use of circular stapler for cervical esophagogastric anastomosis after esophagectomy: surgical technique and early postoperative outcome</title>
            <link>http://www.medworm.com/index.php?rid=2082985&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00913.x</link>
            <description>Stapled esophagogastric anastomosis after esophagectomy is considered to be superior to traditional handsewn techniques. Linear staplers are usually used. The aim of this study is to evaluate early postoperative results of circular stapler in cervical esophagogastric anastomosis. Records of all patients who underwent esophagectomy during the years 2003[ndash]2008 were reviewed. Patients that underwent transthoracic esophagectomy, colon transposition, or linear stapler anastomosis were excluded. Esophagogastric anastomosis was done either handsewn or using circular stapler. Patients underwent either pyloromyotomy, pyloroplasty, or no pyloric intervention. Postoperative leakage was diagnosed either clinically or radiologically. The end-point of this study was the incidence of anastomotic lea...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082985</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082985</guid>        </item>
        <item>
            <title>Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2082984&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00910.x</link>
            <description>The role of neoadjuvant therapy in the treatment of locally advanced esophageal carcinoma still remains controversial. The aim of this study was to evaluate the effects of neoadjuvant radiochemotherapy on pathological staging and prognosis in the patients with locally advanced esophageal squamous cell carcinoma. Between January 1991 and December 2000, 473 patients with advanced esophageal carcinoma diagnosed by endoscopic biopsy underwent surgical resection in our center. With informed consent, they were randomized into four groups: neoadjuvant chemotherapy, neoadjuvant radiotherapy, neoadjuvant radiochemotherapy, and surgery alone (control group). The preoperative computed tomography staging criteria were the following: Stage I, the tumor limited to the esophageal lumen or the thickness o...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082984</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082984</guid>        </item>
        <item>
            <title>Heterotopic gastric mucosa (inlet patch) in a patient with laryngopharyngeal reflux (LPR) and laryngeal carcinoma: a case report and review of literature</title>
            <link>http://www.medworm.com/index.php?rid=2082983&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00915.x</link>
            <description>The inlet patch is an area of heterotopic gastric mucosa most commonly located in the postcricoid portion of the esophagus at, or just below, the level of the upper esophageal sphincter. Esophageal and supraesophageal symptoms are commonly associated with inlet patch, while esophageal adenocarcinoma rarely complicates it. Laryngeal adenocarcinoma associated with inlet patch is not described in the literature. Herein, we present the first reported case of inlet patch associated with laryngeal carcinoma. A 33-year-old female with long-standing asthma and presumed gastroesophageal reflux developed laryngeal cancer at age 22 years that was treated with concomitant radiation and induction chemotherapy. Subsequently, she had refractory heartburn, dysphagia, and cough. These symptoms continued de...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082983</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082983</guid>        </item>
        <item>
            <title>Evaluation of the response to treatment in patients with idiopathic achalasia by the timed barium esophagogram: results from a randomized clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2082982&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00914.x</link>
            <description>To choose which treatment would be most effective for the individual patient with newly diagnosed achalasia is difficult for the tending physician. A diagnostic tool that would allow prediction of the symptomatic and functional response after treatment for achalasia is therefore needed. The timed barium esophagogram (TBE) is a method that allows objective assessment of esophageal emptying, but the value of TBE in the clinical management of achalasia remains to be clarified. The aim of this study was first, to assess the ability of TBE to predict symptoms and treatment failure during post-treatment follow-up. Second, to determine whether esophageal emptying as assessed by TBE differs after treatment with pneumatic dilatation or laparoscopic myotomy. Fifty-one patients with newly diagnosed a...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2082982</comments>
            <pubDate>Mon, 05 Jan 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2082982</guid>        </item>
        <item>
            <title>Defining the lymph node burden in a Northern European population without malignancy: the potential effect of geography in determining a need for FNA?</title>
            <link>http://www.medworm.com/index.php?rid=2058677&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00900.x</link>
            <description>Data from the USA suggest that morphological specificity is insufficient to permit an assumption of malignancy in nodal staging with endoscopic ultrasound (EUS). This may not hold true elsewhere as the background lymph node burden may vary in different geographic regions. We aimed to assess the prevalence and features of mediastinal and abdominal lymph nodes at EUS in a Northern European population without malignant disease. A total of 129 consecutive patients without malignant disease referred for radial EUS were prospectively evaluated for the prevalence and echo features of lymph nodes in the mediastinum and upper abdomen. Sixty-two percent of patients had mediastinal lymph nodes and 17% had abdominal nodes at EUS. A mean of 1.4 (standard deviation 1.3, range 0[ndash]8) nodes were found...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058677</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058677</guid>        </item>
        <item>
            <title>Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route</title>
            <link>http://www.medworm.com/index.php?rid=2058676&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00898.x</link>
            <description>We studied the influence of circumferential resection margin (CRM) involvement on survival in patients with malignancies of the distal esophagus and gastroesophageal junction. One hundred ten consecutive patients undergoing a laparoscopic or open transhiatal esophagectomy for malignancy of the distal 5 cm of the esophagus, or a Siewert I gastroesophageal junction tumor were analyzed, retrospectively. Only patients with potentially resectable tumors were included. CRM status was defined as clear or involved (microscopic tumor within 1 mm of the resection margin). Statistical analysis was done by means of univariate and multivariate analysis using the Kaplan[ndash]Meier method and Cox proportional hazard model. One hundred ten patients were analyzed. Sixty patients underwent open transhiatal...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058676</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058676</guid>        </item>
        <item>
            <title>Diagnostic criteria and surgical procedure for megaesophagus &amp;#x2013; a personal experience</title>
            <link>http://www.medworm.com/index.php?rid=2058675&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00897.x</link>
            <description>Megaesophagus is the end-stage of achalasia cardiae. It is the result of peristaltic disorders and slow decompensation of the muscular layer of the esophagus. The aim of this article is to detail the diagnostic criteria and surgical management of megaesophagus. Criteria were acute bending of esophagus axis; lack of esophagus peristalsis, and no response to stimulation in the manometric test; and Los Angeles C/D esophagitis in the endoscopic examination. Between 1991 and 2004 seven patients (5 females, 2 males; age, 51[ndash]67 years; average age, 59 ± 8 years) were treated. A bypass made from the pedunculated part of the jejunum connecting the part of esophagus above the narrowing with the praepyloric part of the stomach was made. Access was by an abdominal approach. A jejunum bypass was ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058675</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058675</guid>        </item>
        <item>
            <title>Worldwide esophageal cancer collaboration</title>
            <link>http://www.medworm.com/index.php?rid=2058674&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00901.x</link>
            <description>The aim of this study is to report assemblage of a large multi-institutional international database of esophageal cancer patients, patient and tumor characteristics, and survival of patients undergoing esophagectomy alone and its correlates. Forty-eight institutions were approached and agreed to participate in a worldwide esophageal cancer collaboration (WECC), and 13 (Asia, 2; Europe, 2; North America, 9) submitted data as of July 1, 2007. These were used to construct a de-identified database of 7884 esophageal cancer patients who underwent esophagectomy. Four thousand six hundred and twenty-seven esophagectomy patients had no induction or adjuvant therapy. Mean age was 62 ± 11 years, 77% were men, and 33% were Asian. Mean tumor length was 3.3 ± 2.5 cm, and esophageal location was upper...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058674</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058674</guid>        </item>
        <item>
            <title>Gastrointestinal quality of life in patients after anti reflux surgery</title>
            <link>http://www.medworm.com/index.php?rid=2058673&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00895.x</link>
            <description>A subset of patients does not report improvement of symptoms or satisfaction after antireflux surgery. The aim of this study is to assess the effect of pre-existing depression as a factor in patient satisfaction and gastrointestinal quality of life index (GIQLI) outcomes after antireflux surgery. Patients undergoing antireflux surgery who had filled a preoperative quality of life score and had more than 1 year follow-up were included in this study. Based on available history and self-reported medication use, patients were divided in two groups: with depression (group A) and without depression (group B). Fifty-four patients with completed preoperative GIQLI questionnaire were contacted for this study; 32 (59%) patients completed the postoperative questionnaire. Seven patients (22%) had psyc...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058673</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058673</guid>        </item>
        <item>
            <title>Is the etiology of eosinophilic esophagitis in adults a response to allergy or reflux injury? Study of cellular proliferation markers</title>
            <link>http://www.medworm.com/index.php?rid=2058672&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00896.x</link>
            <description>Recent research suggests that allergy may be the key factor in the etiology of eosinophilic esophagitis (EE); however, historically, the condition was hypothesized as related to reflux injury to the esophageal mucosa. We studied this hypothesis by comparing markers of inflammation and cellular proliferation in EE and reflux esophagitis. Lower esophageal biopsies of adult patients with EE (n = 10), reflux esophagitis (n = 8), and normal controls (n = 13) were assessed quantitatively for the expression of the cyclooxygenase-2 (COX-2) enzyme, cellular proliferation, and oncogenic resistance to apoptosis using monoclonal antibodies for COX-2, Ki-67, and Bcl-2, respectively. Normal esophageal epithelium demonstrated weak diffuse uptake of COX-2 stain in the basal layer. No COX-2 expression was ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058672</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058672</guid>        </item>
        <item>
            <title>A rare case of multiple myeloma initially presenting with pseudoachalasia</title>
            <link>http://www.medworm.com/index.php?rid=2058671&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00903.x</link>
            <description>We present here a rare case of multiple myeloma initially presenting with dysphagia because of esophageal amyloidosis and manometric findings typical of achalasia. (Source: Diseases of the Esophagus)</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058671</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058671</guid>        </item>
        <item>
            <title>Influence of aspirin and cigarette smoke extract on the expression of cyclin D1 and effects of cell cycle in esophageal squamous cell carcinoma cell line</title>
            <link>http://www.medworm.com/index.php?rid=2058670&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00899.x</link>
            <description>The relationship between smoking and esophageal squamous cell carcinoma (ESCC) has been confirmed by epidemiology. Cyclin D1 plays a critical role in regulating the cell cycle; it is an important regulator of cell cycle and can function as a transcriptional co-regulator. The importance of cyclin D1 makes it an attractive target for anticancer therapy. Human ESCC cell line EC109 was cultured with aspirin and cigarette smoke extract (CSE) at different concentrations for 48 h. Cell growth was tested with 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide reduction assay; cyclin D1 mRNA level was detected by reverse transcription-polymerase chain reaction assays; protein level of cyclin D1 was detected by Western blot; the cell cycle change was monitored by flow cytometry detection a...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058670</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058670</guid>        </item>
        <item>
            <title>Anastomotic dilatation after repair of esophageal atresia with distal fistula. Comparison of results after routine versus selective dilatation</title>
            <link>http://www.medworm.com/index.php?rid=2058669&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00902.x</link>
            <description>After repair of esophageal atresia with distal fistula (EADF), anastomotic dilatations are often required. We abandoned routine dilatations (RD), in 2002, for selective dilatations (SD) only when the symptoms arose. We compared the number of dilatations and long-term results after RD and SD. Eighty-one successive EADF patients from 1989 to 2007 (RD 46, SD 35), with primary anastomosis, native esophagus, and peroral feeding, were included. Spitz classification, birth weight, gestational age, incidence of gastroesphageal reflux, tracheomalacia, and postoperative complications did not differ statistically significantly between the groups whereas the total incidence of associated anomalies in RD group was higher than in SD (P &lt; 0.05) In RD group, anastomotic dilatations were begun 3 weeks post...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058669</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058669</guid>        </item>
        <item>
            <title>Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study</title>
            <link>http://www.medworm.com/index.php?rid=2058668&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00905.x</link>
            <description>In patients undergoing chemoradiotherapy for esophageal cancer, the inability to eat may severely impair nutritional status. We conducted a retrospective study to compare the efficacy of the Polyflex self-expanding silicone stent (PS) versus a jejunostomy tube (JT) for maintaining nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer who were scheduled for resectional surgery. Thirty-six patients were treated either with PS placement (12 patients) or JT placement (24 patients) prior to receiving an 8-week course of chemoradiation therapy. Patients were interviewed weekly until cessation of therapy. Patient data were collected on procedural success and complication rates, nutritional status, and dysphagia scores. PS placement was successful in 11 of 12 patie...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058668</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058668</guid>        </item>
        <item>
            <title>Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in Shanghai, China</title>
            <link>http://www.medworm.com/index.php?rid=2058667&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00904.x</link>
            <description>The prevalence of gastroesophageal reflux disease (GERD) in China is lower than that in the Western countries, but appears to be increasing. The aim of this pilot study was to evaluate the prevalence of GERD in Shanghai, China, and to explore which population characteristics where associated with GERD. A sample of 1200 adult inhabitants of Shanghai, selected using randomized, stratified, multi-stage sampling, completed Mandarin translations of the Reflux Disease Questionnaire and GERD Impact Scale. Potential risk factors for GERD were examined by nested case-control analysis, using Cochran[ndash]Armitage trend testing and logistic regression analysis. The response rate was 86.2%; 919 responses were suitable for analysis. The prevalence of GERD, defined as heartburn and/or regurgitation of ...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2058667</comments>
            <pubDate>Mon, 22 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2058667</guid>        </item>
        <item>
            <title>Endoscopic pneumatic balloon dilation in primary achalasia: predictive factors, complications, and long-term follow-up</title>
            <link>http://www.medworm.com/index.php?rid=1973333&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00874.x</link>
            <description>Pneumatic dilation (PD) has been widely used in the treatment of idiopathic achalasia with a 70[ndash]90% response. The aim of this study was to evaluate the effectiveness of PD and its predictive factors by means of clinical assessment. In addition, we evaluated its safety and the need for subsequent surgical intervention. Fifty-six patients were treated with a Witzel dilator. The response was evaluated at medium (1[ndash]5 years) and long term (&gt;5 years). Diverse possible predictive factors to response were analyzed. After the first PD, 85.7% of the 56 patients improved and passed from clinical stage II-III to clinical stage 0[ndash]I (P &lt; 0.005). After the second dilation, 84.6% of the patients (13) passed to clinical stage 0-I (P &lt; 0.05). Only patients who were not young (&gt;40 years) av...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1973333</comments>
            <pubDate>Wed, 19 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1973333</guid>        </item>
        <item>
            <title>Gene silencing of &amp;szlig;-catenin by RNAi inhibits cell proliferation in human esophageal cancer cells in vitro and in nude mice</title>
            <link>http://www.medworm.com/index.php?rid=1973332&amp;cid=s_30387_17_f&amp;fid=30387&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1442-2050.2008.00875.x</link>
            <description>ß-catenin, which is frequently overexpressed in a variety of human cancers including esophageal cancer, mediates cancer cell proliferation and tumor growth. In the present study, we used a human U6 promoter-driven DNA-template approach to induce short hairpin RNA (shRNA)-triggered RNA interference to silence ß-catenin gene expression in human esophageal squamous cell carcinoma cell line Eca-109, and then evaluated its effects on the proliferation and growth of tumor cells in vitro and in nude mice. ß-catenin expression levels decreased markedly in Eca-109 cells transfected with a plasmid expressing shRNA for ß-catenin. Downregulation of ß-catenin was concomitantly accompanied by reduction of cyclin D1, colony formation, and growth inhibition of Eca-109 cells in vitro. The mechanism ap...</description>
            <author>Diseases of the Esophagus</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1973332</comments>
            <pubDate>Wed, 19 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1973332</guid>        </item>
    </channel>
</rss>
